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FOREWORD 
The Internet has provided pharmaceutical companies with an unprecedented 
opportunity to interact with physicians. Pharmaceutical companies are seeking to 
reach physicians at a time when they are searching for medical information. But 
whether these efforts work or not, is still in question. Based on such a sense, the 
purpose of this study is to firstly understand the expectations of physicians from the 
online sources of the pharmaceutical companies, and further clarify the effects of 
online marketing efforts of pharmaceutical companies, on the prescription 
behaviours of physicians. 
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ONLINE MARKETING ACTIVITIES OF PHARMACEUTICAL FIRMS 
AND THEIR EFFECTS ON PHYSICIANS’ PRESCRIPTION  BEHAVIOUR 
SUMMARY  
This study aims to analyze what kind of information physicians need in online media 
and what kind of value supplying this need will bring to pharmaceuticals.  
Previous studies have formed a basis for the needs of this research. The internet is 
undoubtedly one of the biggest social revolutions of our times and has a great 
potential to contribute to improving worldwide health outcomes by increasing health 
literacy and access to information. We know that healthcare information is the 
number one reason for internet use, and physicians are heavy users of internet, 
compared to other professions. Recently, pharmaceutical companies have started to 
utilize online marketing channels. But understanding what kind of information 
physicians need and what consequences supplying this need will bring to 
pharmaceutical companies is still in question. Understanding these will better help 
pharmaceutical companies to design their efforts in online media. Therefore, 
marketing budgets can be allocated more productively to maximize returns.  
To test these questions, this study reveals two “pathways” that describe why 
pharmaceutical companies should incorporate the Internet into their practice.  
Our model states that the website quality  of a pharmaceutical company has positive 
effect on the prescription behaviours of the physicians that visit this company’s 
website. This effect comes both directly from the web site and also through 
increasing the company’s image.  
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İLAÇ FİRMALARININ İNTERNET ÜZERİNDEKİ PAZARLAMA 
FAALİYETLERİNİN,  HEKİMLERİN REÇETELEME DAVRANIŞLARINA 
ETKİSİ 
ÖZET  
Bu çalışmanın amacı, doktorların internet üzerinde ne gibi bilgilere değer 
verdiklerini daha iyi anlamak ve bu bilgileri sağlamanın ilaç firmalarına ne gibi 
getirileri olacağı ile ilgili bir model sunmaktır.  
Geçmiş literatür  çalışmalar, bu çalışma için bir temel oluşturmuştur. İnternet, 
günümüzün tartışmasız en önemli devrimi halini almıştır ve sağlık konusunda bilgiye 
ulaşım hızını arttırarak sağlık alanında da devrim yaratmak üzeredir. Bildiğimiz 
kadarıyla internet üzerinde sağlık, en çok araştırma yapılan konulardan biridir ve 
doktorlar diğer mesleklerle karşılaştırıldığında interneti oldukça yoğun 
kullanmaktadırlar. . Son zamanlarda ilaç firmaları, doktorlarla iletişim kurmak için 
internet kanalından faydalanmaya başlamıştır. Fakat doktorların bilgi ihtiyaçları ve 
bu ihtiyaçları karşılamanın getirisinin ne olacağı konularında tartışma sürmektedir. 
Bu ihtiyaçları daha iyi anlamak, ilaç firmalarının bütçelerini daha faydalı bir şekilde 
dağıtıp sağlanan faydaları ölçebilmelerine olanak verecektir. 
Bu sorunlara çözüm aramak amacıyla çalışmamız, ilaç firmalarının interneti neden 
daha yoğun kullanmaları gerektiğini iki yoldan açıklamaktadır. 
Bu çalışmada sunulan modele göre bir ilaç firmasının web sitesi, o web sitesini 
ziyaret eden doktorların reçeteleme davranışları üzerinde pozitif etki yaratmaktadır. 
Bu etki, hem doğrudan web sitesinin etkisinden, hem de firma imajını arttırarak imaj 
değişkeni üzerinden gelmektedir. 
xv 
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1. INTRODUCTION 
Pharmaceuticals is a highly globalized industry, dominated by multinational 
companies that engage in significant business activity in many countries and whose 
products are distributed and marketed worldwide. The industry has undergone 
dramatic structural changes over the past few decades, with the rise of the 
biotechnology sector, substantial growth in demand driven by demographics and 
substitution away from other therapeutic modalities such as surgery, and increased 
competition from globally active generic manufacturers. (Cockburn, 2007)  
More than ever before, the pharmaceutical industry today is faced with complex and 
critical challenges in the market place. The competition from generic manufacturers 
has become fierce, and patent protections are still an issue . Finally and most 
challenging, marketers are being held accountable for their budget allocations as 
measured by the number of new prescriptions. An increase in measurement emphasis 
and accountability results in the pharmaceutical industry questioning it’s traditional 
marketing approach. This shift is causing marketers to shift away from popular 
detailing practices to more innovative approaches. Rising R&D expenditures in the 
face of health care cost containment pressures and apparently slowing research 
productivity give pharmaceutical companies a powerful incentive to seek out cost 
savings and new models for innovation. In an effort to find new avenues to 
efficiently reach their target segments and gain insight into their preferences, 
marketing teams have begun to adopt personalized new technologies. 
The explosive development of the internet in the last ten years has created new 
commercial opportunities. Despite the strict regulations enforced by national states, 
the online presence of medicines came onto the web by an increasing number of 
pharmaceutical web sites. (Gurau, 2005) 
However, especially in emerging countries, using new technologies like the Internet 
for marketing purposes is still a challenge for the pharmaceutical industry.  Firms 
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usually keep their circumspection towards online spending because they do not 
know, how online activities impact physicians and their prescribing behavior. 
This work aims to contribute to the literature by analyzing physicians’ point of view 
towards online activities of pharmaceutical firms. Understanding what kind of 
information physicians need and what kind of presentation they value will better help 
pharmaceutical companies to design their efforts in online media. Therefore, 
marketing budgets can be allocated more productively to maximize returns.
3 
2. LITERATURE REVIEW 
2.1 Marketing Communications 
For the past decade, academics and practitioners alike have looked to research 
textbooks, shared knowledge through conferences and seminars and field practice to 
define and apply marketing communication – that is, what it is, how it works in 
practice, and what it might most contribute to marketing communication and brand 
development in the future. Descriptive studies have investigated practitioner 
perceptions of  it, organisational structures and challenges in implementation of 
marketing communication tools. Process models have been developed and theory 
drawn from these observations in an attempt to better understand the foundations of 
marketing communications and to identify future research directions.  
Before looking at marketing communications, we should consider briefly marketing.  
The marketing mix is essentially a conceptual framework that helps to structure the 
approach to the marketing challenge. The marketing mix approach is one model of 
crafting and implementing marketing strategies. It recognizes that marketers have 
essentially four variables to use when crafting a marketing strategy and writing a 
marketing plan. They are price, promotion, product and distribution (also called 
placement). They are sometimes referred to as the four p's.  
A marketing mix is a combining of these four variables in a way that will meet or 
exceed organizational objectives. A separate marketing mix is usually crafted for 
each product offering.  
Some commentators have increased the number of p's in the mix to 5, 6 or even 8. 
"People" is sometimes added, recognizing the importance of the human element in 
all aspects of marketing. Others include "Partners" as a mix variable because of the 
growing importance of collaborative channel relationships. Others feel that it is not 
an appropriate model for some types of marketing, particularly industrial product 
marketing and services marketing. The original 4 P's of marketing that were the 
elements of a marketing mix are: 
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Product: Product decisions defines the real physical product characteristics which 
might include product brand name, quality, packaging, functions, after sales services, 
etc. 
Pricing : Pricing decisions includes list, retail, wholesale, seasonal pricing, volume 
discounts, early-bird discounts, bundled pricing, flexible pricing, consignment 
options etc. 
Placement : Placement  decisions essentially means distribution channels which 
utilize to bring products to the customers. Extent of coverage in the  market could be 
defined by inclusive or exclusive or selective distribution. Distribution and 
warehousing centers, inventory management as well as logistics. Internal extension 
of sales distribution is a common consideration. 
Promotion : Promotions decisions is the final phase of the marketing mix which, to 
certain extent could make or break a product. This is the phase where the product is 
communicated to  target segments with communication tools available. The 
promotional mix includes Advertising & Promotions, personal selling, sales 
promotions, public relations and publicity as well as sponsorships. The Promotion 
element can be defined as ‘marketing communication’, which includes selling, 
advertising, sales promotion,,direct marketing, publicity, sponsorship, exhibitions, 
packaging, point of sale, word of mouth, e-marketing and corporate identity. 
(Hughes, 2006) 
 
 
4 Ps 
 
 
 
  
 
  
Figure 2.1 :   Promotion (Marketing Communication) Elements 
Traditionally, marketing communication practitioners focus on the creation and 
execution of printed marketing collateral and the like; however, academic and 
Product 
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Place 
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Selling   Advertising 
Sales Promotion Direct Marketing 
Publicity  Sponsorship 
Exhibitions  Packaging 
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e-Marketing  Corporate Identity 
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professional research developed the practice to use strategic elements of branding 
and marketing in order to ensure consistency of message delivery throughout an 
organization. Many trends in business can be attributed to marketing communication; 
for example: the transition from customer service to customer relations, and the 
transition from human resources to human solutions. In branding, opportunities to 
contact stakeholders are called brand touchpoints (or points of contact.) Marketing 
communication is concerned with the general behavior of an organization and the 
perceptions of the organization that are promoted to stakeholders through these 
touchpoints. 
Marketing communications is focused on product/produce/service as opposed to 
corporate communications where the focus of communications work is the 
company/enterprise itself. Marketing communications is primarily concerned with 
demand generation, product/produce/service positioning while corporate 
communications deal with issue management, mergers and acquisitions, litigation 
etc. (Kerr and others, 2008) 
2.1.1 Integrated  Marketing Communications 
 
IMC (Integrated Marketing Communications) essentially is a management approach 
that aligns and optimizes the communications impact of various disciplines.  
American Association (1989) defines it as a concept of marketing communications 
planning that recognises the value in a programme that integrates a variety of 
strategic disciplines – e.g. general advertising, direct response, sales promotion and 
public relations – and combines these disciplines to provide clarity, consistency and 
maximum communication impact. 
Schultz  (1991) defines it as the process of managing all sources of information about 
a product/service to which a customer or prospect is exposed, which behaviourally 
moves the customer towards a sale and maintains customer loyalty. 
According to Kotler (1999), IMC is the concept under which a company carefully 
integrates and coordinates its many communications channels to deliver a clear, 
consistent and compelling message about the organisation and its products. 
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Duncan (2004), says that it’s a cross-functional process for creating and nourishing 
profitable relationships with customers and other stakeholders by strategically 
controlling or influencing all messages sent to these groups and encouraging data-
driven purposeful dialogue with them. 
The concept of integration has existed in advertising and marketing literature for 
many decades, but the practice appears to have been minimally implemented. As 
early as 1930, the need for integration in marketing was recognized by Converse 
(Spotts and others,1998), who urged greater cooperation between the sales team and 
advertising to optimise results (a subject that is still being debated today). Levitt, in 
1960 (Spotts and others,1998), also proposed that the entire business process should 
be an integrated effort. Many others have ‘preached’ integration, but few followers 
have developed. This is clearly evident from the continuation of the functional silos 
found in almost all advertising, communication, promotion and marketing practices, 
educational courses and academic journals. The concept of integration has also been 
recommended for promotion. 
A series of articles written between 1991 and 1996 have outlined the specific 
dimensions of the IMC concept, presenting it as a logical answer to the problems 
experienced by many business and non-profit organisations. 
Following this phase in which the concept has received the proper legitimacy, a 
series of studies (Kitchen and Schultz, 1999) have initiated an investigation into the 
practical application of the concept by the practitioners – especially US and UK-
based advertising agencies. The conclusions of these studies were complex: on one 
hand, the advertising executives recognised the impact of IMC on increasing the 
effectiveness of creative ideas, providing greater communication consistency, and 
improving the client return on investment; on the other hand, they outlined the 
problems related with measuring the IMC outcomes in terms of time and cost 
efficiencies. 
According to Pickton and Broderick (2001), marketing communications tools that 
were traditionally separated and specialised in “above the line” and “below-the-line” 
activities, should be now integrated under the IMC concept and synergy is the 
principal benefit of bringing together the various facets of marketing 
communications in a mutually supportive way.  
7 
 
Other definitions emphasise that the integration of marketing communication should 
not be understood as a simple uniformity of the message transmitted across different 
channels (Kitchen and others, 2004), but rather as the complex coordination and 
management of the information transmitted though complementary channels in order 
to effectively present a coherent image of the organisation to the targeted audiences. 
A good example is the definition proposed by Keegan (1992): 
Integrated marketing communications is the strategic co-ordination of all messages 
and media used by an organisation to collectively influence its perceived brand 
value. This definition focuses on the concept of “strategic coordination”, indicating 
the evolution from tactical coordination towards a more strategic approach, in order 
to realise communication synergies. In addition, the definition considers “all 
messages” highlighting that both internal and external activities contribute to 
marketing communications efforts, and stresses the focus on brand value that 
requires a change of marketing and communication perspective. At the heart of this 
definition is the assumption that the credibility and value of both the company and its 
brands will increase, when messages transmitted to various audiences become 
consistent across time and targets. (Kerr and others, 2008) 
Another definition proposed by Duncan (2004) demonstrates the current conceptual 
perception of IMC: A cross-functional process for creating and nourishing profitable 
relationships with customers and other stakeholders by strategically controlling or 
influencing all messages sent to these groups and encouraging data-driven, 
purposeful dialogue with them. 
An important contribution of this definition is the emphasis on “profitable 
relationships”. 
Moreover, Duncan acknowledges that integrated marketing communications 
involves a cross-functional process. This indicates that all organizational departments 
that interact with customers and strategic stakeholders must share a common 
understanding and work collectively to develop long-term brand relationships. 
Furthermore, the notion of stakeholders implies the shift in the IMC concept from 
customer target audiences to the inclusion of key stakeholder groups such as 
employees, investors, suppliers, distributors, media and the social community. 
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Conceptually, IMC provides an opportunity for organizations to enhance the 
relationship of their brands with customers and other stakeholders. The strategic 
coordination of all marketing and communication tools can lead to a consistent brand 
message directed towards the targeted audiences, using effective media planning. 
This strategy fosters an ongoing consumer-brand relationship which leads to 
profitable outcomes. 
2.1.2 Online Marketing Communications 
The rapid development of the internet in the last ten years has changed the classical 
communication procedures, because of three specific and co-existent characteristics 
that differentiate it from any other communication channel. (Gurau,2005) 
Interactivity. The internet offers multiple possibilities of interactive communication, 
acting not only as an interface, but also as a communication agent (allowing a direct 
interaction between individuals and software applications). 
Transparency. The information published online can be accessed and viewed by any 
internet user, unless this information is specifically protected. 
Memory. The web is a channel not only for transmitting information, but also for 
storing information – in other words, the information published on the web remains 
in the memory of the network until it is erased. 
These options are transforming the profile and the behaviour of online audiences. 
Marketing communication practitioners should therefore adapt to the new realities of 
how audiences get and use information: The audience is connected to the 
organizations. The traditional communication channel was unidirectional – the 
institutions communicated and the audiences consumed the information. Even when 
communication was considered a two-way process, the institutions had the resources 
to send information to audiences through a very wide pipeline, while the audiences 
had only a minuscule pipeline for communicating back to the institutions. 
The audience is connected to one another. Considering the nature of the network, if 
the audience is one click away from the institution, it is also one click away from 
other members of the audience. Today, a company’s activity can be discussed and 
debated over the internet, without the knowledge of that organization. In the new 
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environment everybody is a communicator, and the institution is just part of the 
network. The audience has access to other information. In the past, because of the 
slowness and difficulty to access specific information, the communicator was able to 
make a statement with the reasonable certainty that it would be impossible for the 
average audience member to challenge it. Today, it is easy to access multiple sources 
of information over the internet. Any statement made can be dissected, analyzed, 
discussed and challenged within hours by interested individuals. Audiences pull 
information. The networked world has increased exponentially the number of 
available channels of communication. Today, we get messages from multiple media 
channels: email, voice mail, faxes, pagers, cell phones, interoffice memos, overnight 
courier packages, television (with hundreds of channels), radio, internet radio, etc. 
As a result, the media that used to provide an efficient channel of communication for 
practitioners have become now only noise that most of the audiences have learned to 
filter out. On the other hand, the networked environment provided the audiences with 
a new model, one in which they no longer accept every message a communicator 
wants to push to them, but they rather pull the information that suits their interests 
and needs. In the networked environment, information has to be available where 
audiences can find it, and must be customized or customizable. Therefore, in 
comparison with the traditional customer, the internet user has more control over the 
communication process, and can adopt a more proactive attitude, expressed by the 
capacity to:  easily search, select and access information (using search and meta-
search engines, intelligent agents, etc.); contact online organisations or other 
individuals (using email, chat or discussion forms); and express their opinions/views 
in a visible and lasting manner (creating and storing online content). 
Until now the relationship between brands and consumers has been one way. The 
rules of marketing had to change, and the web has proved a catalyst in bringing the 
changes forward and amplifying their scale. The removal of frictions in the spread of 
information has created a radically different landscape for marketers to work within 
and this is a key element in understanding how the first generation of internet 
marketing works. The sudden emergence of the interactive online marketing 
techniques demand additional approaches, and while most marketers are still 
wrestling with the first generation, savvy brands are exploring the landscape that 
social media and social networks create for marketers. These techniques are allowing 
10 
much deeper drivers in social change to be unleashed, with a profound impact on 
planning customer connections. (Klue, 2008) 
 
Schibrowsky et al. identified three research areas that are believed to grow in the 
near future: (1) the issue of consumer trust in the Internet; (2) the issue of how 
consumers will use the Internet for marketing-related activities in the future; and (3) 
the issue of where the Internet is headed as a marketing tool. 
Kaynak, Tatoglu, and Kula (2005) studied internet businesses in Turkey. A survey 
questionnaire was used to solicit information from managers in randomly selected 
businesses that employed between 10 and 100 persons. Respondents were asked to 
indicate their frequency of use of various e-commerce applications on the Internet. 
The survey also asked respondents to react to a number of commonly understood 
benefits and limitations of e-commerce. The survey was sent to 1,200 companies, 
with a response rate of just under 38 percent.  Kaynak, Tatoglu, and Kula found that, 
in terms of frequency of usage, the highest ranked applications were those associated 
with external communication (i.e., E-mail) and accessing information for market and 
product research. The second most frequently used applications centred on the 
companies’ willingness to do business over the Internet (e.g., exchanging 
information with clients and suppliers; receiving orders from clients; placing orders 
with suppliers). The lowest-ranked group of applications had to do with various 
specific functions, such as using the Internet as a medium of payment, placing job 
recruitment information, and videoconferencing. With regard to perceived benefits, 
the respondents indicated general agreement that the benefits listed in the survey 
were accurate. Among the benefits listed, the following ranked highest: 24-hour 
accessibility; low-cost communication; easy access to international markets; and easy 
access to potential customers. At the other end of the scale, the lowest ranked 
benefits were: decrease in sales staff’s travel time; increase in sales; monitoring the 
performance of competitors; and online sales and operation. In analyzing the data on 
perceived limitations of internet-based e-commerce, the researchers found the 
following were agreed to most often as the major limitations: limited number of 
Internet users; reduced efficiency due to unnecessary Internet use; lack of legal 
regulations; and suppliers and/or customers being offline. On the other hand, the 
respondents showed the lowest levels of agreement with the following statements of 
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limitations: technically complex; no efficiency in operations, no reduction in 
operating costs; and uncertainty regarding message delivery. 
Steenkamp and Geyskens (2006) examined how country characteristics affect the 
perceived value of Web sites among consumers from 23 countries around the world. 
The researchers tested a number of hypotheses to determine whether country 
characteristics moderate the effects of individual-level antecedents of perceived 
value of Web sites of consumer packaged goods producers. Their findings provided 
validation of their conceptual model as most of their hypotheses were supported. For 
example, they found that perceived privacy/security is most important in countries 
characterized by weak rule of law and that perceived privacy/security, pleasure, and 
customization are more important in individualistic countries than in collectivist 
societies. Cultural congruity was more important in countries that ranked high on 
national identity while there was some evidence that utilitarian experience is more 
important to the members of collectivist nations. Overall, the authors suggest that the 
designers of Web sites should develop customized and localized Web sites that take 
into account the moderating effect of country characteristics on individuals’ 
perceptions of Web site value. (Thomas, 2008). 
 Rosenbloom (2002) elucidated ten key beliefs that surrounded and governed the 
realm of e-commerce. These ten beliefs pertained to disintermediation (no 
middlemen), lower costs, real-time product flow, non-significance of profits, first 
mover advantage, market capitalisation worship, sole importance of convenience and 
efficiency, pure play, valuation by publicity, and the internet as a whole new culture. 
(Nataraajan, 2006) 
Taking advantage of the various online resources requires strategic thinking that 
recognizes that all these aspects of the networked world coexist. They must be 
coordinated to achieve specific, measurable objectives consistent with the goals of 
any marketing communication effort. Internet technologies allow online-active 
organisations to implement these main communication synergies. 
(1) The integration and coordination of communication modes: the organisations can 
combine one-to-one (email), one-to-many (list-based email messages, web pages), 
and many-to-many (discussions and forums) communication in the online 
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environment. This synergy increases Meaning Frequency Percentage Combination of 
communication modes. (one-to-one, one-to-many, many-to-many); Integration of 
information types (text, sound, image); Consistency of messages transmitted trough 
the online communication-mix (coherent meaning); Integration of marketing and PR 
communication functions in the messages provided online; The coordination of the 
process: message conception –transmission – feedback reception and analysis, in a 
closed loop;  Coordination of internal, external and internal-external flows of 
information. 
 (2) The integration and coordination of various types of information: the recent 
advances in information and communication technologies (broadband) allow 
organisations to transmit or receive a complex combination of information in the 
form of texts, sounds and images (static and/or dynamic). This synergy has a direct 
effect on the complexity and clarity of the communication, enhancing the capacity of 
the organisation to tailor its messages to the specific needs and requirements of 
various audiences. Unfortunately, complex messages can often create compatibility 
problems.  
(3) The integration and coordination of complex information flows between the 
organisational intranet and the internet. The organisation is now able to implement 
advanced software applications that connect its marketing and management 
information systems with the online environment, and to automatically coordinate 
the communication with various audiences. This capability has a powerful impact on 
multiple aspects of the communication process. 
(4) the capacity to automatically capture and register customer data (demographic or 
behavioural) and customer feed-back. 
(5) the capacity to automatically analyse the information collected about audiences, 
to a level of segmentation and detail that allows the implementation of one-to-one 
marketing communication. 
(6) the capacity to use the existing databases in order to automatically launch and 
coordinate highly targeted communication campaigns (automatic email responses, 
automatic email campaigns, personalised event marketing, promotional news and 
newsletters). 
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2.2 Pharmaceutical Marketing and Communication 
2.2.1 Pharmaceutical Marketing 
The pharmaceutical industry is a prime example of an industry that combines both 
“push” and “pull” strategies in their marketing efforts. 
The “push” strategy, which relies primarily on personal selling and sales promotion 
as a means to “push” a product through the marketing channel, is exemplified by the 
efforts of salespeople who market drugs directly to physicians (Benitez, 2003). The 
other examples include promotional business gifts, events, trade shows, internet 
marketing and public (physician)  relations.  
Pull strategies, which rely on advertising and sales promotion to the consumers and 
physicians to “pull” the product through the marketing channels, are illustrated by 
the annual use of approximately 34,000 advertisements in USA (Adams, 2002) that 
promote both over the counter drugs as well as prescription medications. This growth 
is not expected to decline; Lipman (2000) indicates that these huge amounts of 
advertising effort will have the effect of sending consumers to their physicians 
asking for information about a particular brand of a product or directly asking the 
physician that the product be prescribed to them. 
It seems clear that the combination of these push and pull strategies are aimed at 
increasing the awareness of various types of products by both the consumer (patient) 
and the physician, and ultimately increasing the sale of those products.  
Depending on the category of drug, the nature of the marketing mission is different. 
There are essentially two categories of drugs: self-medication or over the counter 
(OTC) drugs, and prescription drugs. OTC drugs (paracetamol and anti-histamines) 
are promoted directly to consumers as well as physicians and other healthcare 
professionals. What is categorized as OTC varies from country to country and is 
dependent on the local legislative framework – usually a national medicines 
authority. (Buckley, 2004) 
Corstjens (1991) identifies four main buying parties for prescription drugs: 
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1. Prescriber – prescribing rights vary internationally and this category may include 
doctors, dentists, pharmacists, nurses and optometrists 
2. Influencer – hospitals, nurses, professors, reimbursement agencies 
3. Consumer – patient 
4. Financier – partly patient, partly government or third party (varies by country), 
managed health care organization (hospitals, Health Maintenance Organisations etc.) 
Undoubtedly, the greatest power among these is the prescriber. The majority of Big 
Pharma’s marketing budget is targeted at doctors and others with prescribing power, 
who are effectively the gatekeepers to drug sales. Especially in a country like 
Turkey, where Direct to Consumer Advertising (DTCA) is banned, the role of the 
physicians in the pharmaceutical market is significantly determinant.  
Promotion efforts directed at physicians are important for the continued health of the 
pharmaceutical industry. The World Health Organization defines pharmaceutical 
promotion as: “all information and persuasive activities by manufacturers and 
distributors the effect of which is to induce the prescription, supply, purchase, and/or 
use of medicinal drugs”. The companies seek to inform physicians about a drug, 
persuade physicians to write prescriptions for their drug, and remind them of their 
drug throughout its product life cycle in order to maintain the drug’s brand equity. 
Socially responsible pharmaceutical companies will be objective and complete in 
their information dissemination, helping physicians to rationally prescribe 
medications. (Spiller And Wymer, 2001) 
Pharmaceutical companies incorporate advertising, personal selling, sample 
distributions, support via internet, and public relations into their promotion mix. 
Although some physicians working for managed care organizations are forbidden to 
make appointments for detailers, previous research shows that most physicians see 
pharmaceutical representatives on a regular basis.  
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2.2.2 Pharmaceutical Online Marketing 
Technology is giving healthcare and pharmaceutical marketers more means than ever 
to engage their patient and physician customers and make them more accessible. 
While it is imperative to establish meaningful and informative dialogues with 
customers, it is also important to manage them for optimum outcomes. 
Blanckett and Robins(2001) have stated that the future is about to necessitate a 
revolution in the pharmaceutical sector for communication, more widespread 
channels of distribution (including the Internet) and regulatory changes.  
The increasing reliance on the internet by the healthcare community at large has been 
shaping the practice of health communication by opening  the way to the use of 
interactive health communications tools (Web sites, Internet-based games, online 
press rooms, disease symptoms simulations, opinion polls, seminars, etc.), which are 
often designed as part of larger health communication interventions. Professional and 
personal blogs, podcasts, chat rooms and forums have also become a prominent 
source of health information among different kinds of audiences. E-health emerged 
as a general buzzword after 1999 and is defined as  “a field in the intersection of 
medical informatics, public health and business, referring to health services and 
information delivered or enhanced through the Internet and related technologies”. 
(Schiavo, 2007) 
Ultimately, the internet is increasingly being perceived as an important 
communication  channel and is functioning as some of the more established 
channels.  
The advent of the World Wide Web and the Internet has made it possible for 
healthcare providers to publicize their offerings through this technological route. 
Healthcare organizations were slow to jump onto the Internet bandwagon but 
recently there has been a surge of interest. However, the fact remains that progress in 
this area has remained uneven in many organizations. As in other aspects of 
marketing, websites oriented towards healthcare marketing are frequently targeted 
for cutbacks when budgets are tight. (Thomas, 2006) Another drawback is that, 
healthcare is recognized as a regulated industry with many restrictions on account of 
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product-labeling and consumer privacy issues. Companies in some cases want to stay 
in comfort zones by avoiding innovations such as Internet marketing.  
(Venkatesh, 2001) 
Pharmaceutical companies progresses through different stages. The first stage 
involves a brochure site indicating who they are and what they do. Most 
pharmaceutical companies have passed through this stage, but beyond that they are 
all over the board in terms of information provision, interactivity, and relationship 
building. The public interest in online healthcare information continues to grow. It 
remains to be seen if drug companies and provider organizations, will be the 
preferred source of health-related information or whether these functions will be 
carried out by the Web MDs of the Internet world. (Venkatesh, 2001) 
Schiavo (2006) has identified the key issues in online health communication  
• A true understanding of situations and needs as well as audience 
characteristics and health literacy levels.  
• The quality and scientific resonance of the information being presented. 
• The development of well-defined goals and objectives for the online health 
communication intervention. 
• A behaviour-oriented mindset , which should prompt consideration for the 
kind of behaviour online communications seek to influence. 
• The information’s graphic appeal — Showing instead of telling is a good 
practice in most forms of communications and, in the case of internet-based 
communications, it is both an obvious opportunity and a strategic imperative. 
Somewhat, this may have a different weight for internet uses that seek to 
expand the circulation of print materials or create online access to specific 
information (eg online libraries, e-journals, e-books, etc) but it is a prominent 
factor for all other internet applications. 
• The cultural competence of online information and tools, which should be 
designed to reach across cultural boundaries and intended audiences’ ideas of 
health and illness.  
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Data from a study by Flanagin and Metgzer (2001) showed that  conversation 
features of the Internet align with mediated interpersonal technology (the telephone 
and electronic mail). Similarly, internet use for giving and retrieving information is 
widespread. Information-related features are often used in ways that are similar to 
more traditional mass media channels, including print, broadcast and books .  
Still, the influence of the internet and other related technologies varies from 
population to population and group to group. It is related to media access as well as 
specific media uses and preferences among members of intended audiences. 
The accuracy and quality of the information retrieved or exchanged on the internet is 
a key issue that may affect perception of the overall field of online health 
communications as well as its use among some audiences.  
Schiavo (2006) included examples of some of the key factors that influence online 
communications quality in the healthcare field.  
• Evidence-based, referenced and regularly updated information 
• Peer review or professional authorship process 
• Transparency about information source and/or health organisation’s history, 
mission, activities and goals 
• Information endorsement by key opinion leaders (KOLs) and other health 
organisations 
• Source accreditation by reputable accrediting institutions 
• Grant and conflict of interest disclosure 
• Clarity on intended use of personal data 
• Reputable and/or community-based sources and spokespeople 
• Culturally competent format that translates into visual and graphic appeal, 
and adequate use of language 
• Easy navigation 
• Audience-driven resources and tools, including audience feedback 
mechanisms 
• Inclusion of design features and tools that help create bridges among different 
key audiences 
• Integration with services and other health communication interventions.  
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2.2.3 The Quality of Pharmaceutical Websites 
The principal dilemma of the internet is that, while its anarchic nature is desirable for 
fostering open debate without censorship, this raises questions about the quality of 
information available, which could inhibit its usefulness. 
Quality is defined as “the totality of characteristics of an entity that bear on its ability 
to satisfy stated and implied needs.” (Bell and Tang, 1998) For quality to be 
evaluated, these needs have to be defined and translated into a set of quantitatively or 
qualitatively stated requirements for the characteristics of an entity that reflect the 
stated and implied needs.  
Construct measurement in general and in the context of web technologies and 
applications in particular is a challenging task, hence, deserves more attention from 
researchers interested in this phenomenon. However, web site quality measurement 
is neither simple nor straightforward. Web quality is a complex concept; therefore, 
its measurement is expected to be multi-dimensional in nature. Current research on 
web quality seems to pay less attention to construct identification and measurement 
efforts. Only limited academic research exists, but it is fragmented and usually only 
discusses the meaning of some aspects of web quality. At the practitioner level, 
several commercial ranking systems are available to rate web sites according to 
certain quality attributes, e.g. Web Awards (www.webaward.org) and The Web 
Awards  (www.thewebawards.com). These ratings, however, lack clarity in terms of 
criteria used and the ranking methodology. Also these are not targeted towards a 
specific area, like healthcare. 
Web quality is a vastly undefined concept. For the most part, existing scientific 
research discusses the meaning of some aspects of web quality in a descriptive 
manner without delineating its major dimensions or providing tested scales to 
measure it. For example, Liu and Arnett (2000) named such quality factors as 
accuracy, completeness, relevancy, security, reliability, customization, interactivity, 
ease of use, speed, search functionality, and organization. Huizingh (2000) focused 
on two aspects of web quality: content and design. Wan (2000) divided web quality 
attributes into four categories: information, friendliness, responsiveness, and 
reliability. The authors highlighted the importance of factors such as download 
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speed, web interface, search functionality, measurement of web success, security, 
and Internet standards.  
Kim and Others (1999) defined perceived web quality as users’ evaluation of a web 
site’s features meeting users’ needs and reflecting overall excellence of the web site 
and identified three dimensions of web quality: technical adequacy, web content, and 
web appearance. The sample items were initially assessed using a Delphi method. 
Two information systems scholars were asked to evaluate the items and make 
changes to eliminate repetitive items, technical/non-user oriented items, and sub-
attributes of higher level attributes. After three evaluation rounds, 55 web quality 
attributes remained in the list.  In first stage of data collection, the 55-item instrument 
was administered to student web users enrolled in three different sections of an 
introductory information systems class at a business school. The reliability levels for 
the reduced web quality dimensions came as 0.89, 0.86 and 0.81 for technical 
adequacy, web content, and web appearance, respectively. Their final categorization 
is below: 
• Technical adequacy  :  Security; ease of navigation; broadcast services; 
limited use of special plug-ins; search facilities; anonymity; availability; valid 
links; reliability; browser sniffing; personalization or customization; speedy 
page loading; interactivity; ease of access; multi-language support; protected 
content; bookmark facility 
• Web content : Usefulness of content; completeness of content; clarity of 
content; uniqueness of content; broadness of content; originality of content; 
currency of content; conciseness of content; accuracy of content; finding 
contact info.; finding people without delay; finding site maintainer; finding 
links to relevant sites; finding firm’s general info.; finding products/services 
details; finding customers’ policies; finding customer support; finding FAQ 
list; finding free services; using limited registration forms; finding online 
help; diversity of content; finding free info 
• Web appearance : Attractiveness; distinctive hot buttons; changing look; 
organization; proper use of fonts; proper use of colors; proper use of 
graphics; graphics-text balance; proper use of multimedia; style consistency; 
proper choice of page length; good labeling; text-only option; proper use of 
language/style; color  
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Eysenbach and others (2002) have recognised the specifications of online health 
information.  
• Complete lack of quality control at stage of production, leading more easily 
to lack of reliability. 
• A “context deficit” leading to situation where information does not 
necessarily have to be false to harm. 
• Less clear “markers” than in traditional publishing to allow patients to easily 
recognise a document as intended for professionals rather than for patients. 
Patients reading information intended for health professionals may 
misinterpret information, leading to false expectations about treatment 
options, etc 
• It is possible to read a web page without having seen context pages or the 
“cover” page containing disclaimers, warnings, etc 
• Anonymity (of authors) may cause additional problems. Authors of web 
pages, news articles, emails, etc, sometimes remain unidentified 
• Health information that is valid in a specific healthcare context may be wrong 
in a different one: “A free market of information will conflict with a 
controlled market in health care” 
Kim and Others, (1999) has done a study which  reviews criteria currently proposed 
or employed specifically to evaluate health related web sites. Between September 
1997 and May 1998 they  conducted a search of the web and peer reviewed medical 
journals for criteria for evaluating health related information on the web using 
Medline and Lexis-Nexis databases, and web search engines including Yahoo!, 
Excite, Altavista, Webcrawler, HotBot, Infoseek, Magellan Internet Guide, and 
Lycos.  Not surprisingly, “content” of the site, which includes concepts of 
information quality and accuracy, was the most commonly cited criterion group. 
Design and aesthetics of the site and ease of use were the second and sixth most 
frequently cited groups respectively, indicating that authors highly value good 
quality application design and user interfaces. Disclosure of authors, sponsors, or 
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developers had the third highest frequency, highlighting the need for users to be able 
to consider a site's content in the context of who created or financed the site. It was 
somewhat surprising that disclosure was not more commonly cited given recent 
reports about misleading health information and fraud on the internet. Most rating 
tools discriminated between content and the fourth most common criterion group, 
currency of information (includes frequency of update, freshness, maintenance of 
site), suggesting that currency of information is nearly as important as the 
information itself. 
Criteria related to confidentiality and privacy of information were only cited by one 
author despite widespread interest in this issue. Some health related web sites are 
already collecting personal health information to “tailor” content, and as sites begin 
to integrate healthcare services and information, confidentiality and privacy 
safeguards will become increasingly important. 
Risk and Dzenowagis (2001) have addressed the complexity of the issues 
surrounding quality of health information in the context of  Internet. In their search, 
some of the key self-regulation initiatives of Internet health information quality have 
been described and analyzed. Their research  clarifies and discusses the issues and 
requirements for the further development of Internet health information quality. They 
point out that there is an urgent requirement to examine the needs of the developing 
world and the info-poor in relation to quality of Internet health information, products, 
and services. This is a reflection on how poorly the current batch of quality initiatives 
have addressed those needs. This examination would include determining whether or 
how quality standards can help developing countries, especially where regulatory 
agencies are weak or nonexistent; or where there is excessive, uninformed, or 
onerous regulation. Another discussed issue is that, there is a need for coordination 
and harmonization of the efforts striving towards quality health information on the 
Internet. This extends to the key players in both the self-regulation and the 
mainstream and regulatory camps, and includes regional and international bodies, the 
health care products industry, foundations with an explicit interest in Internet health 
information, private and corporate interests, and citizen and country representation 
and participation. 
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In Turkey, the research-based pharmaceutical industry strongly supports and 
encourages the appropriate use of the Internet and related technologies to provide 
accurate and scientifically reliable information on health care and medicines, as well 
as providing information in a responsible manner, for the benefit of patients, 
healthcare professionals, and all who have an interest in human health and the proper 
use of medicines. Medicines and health issues are important areas for the 
communities. Patients as well as health professionals (physicians, pharmacists, 
nurses, etc.), wish to get unbiased, up-to-date, clear and concise information related 
to the health issues and medicinal products. The Turkish Pharmaceutical 
Manufacturers Association (IEIS) is a nonprofit and nongovernmental private 
organization established in 1964.  Considering the particular characteristics of 
medicines, the pharmaceutical industry should adhere to special ethical criteria, when 
promoting their products. A Code has been prepared by the IEIS with the intention of 
establishing and maintaining high ethical standards in the promotion of medicines 
and other pharmaceutical products in Turkey. Conveyance of such information 
should conform to the general rules set by the Turkish Ministry of Health, be in good 
taste and comply with ethical criteria.  
IEIS published the latest form of medicinal product promotion guidelines on January 
1, 2003. Appendix A contains the section entitled as “Pharmaceutical Companies’ 
Internet Web Site Application Guidelines”. 
Based upon these guidelines, Yeğenoğlu and others (2005) proposed a research to 
determine to what extent the pharmaceutical companies in Turkey comply with these 
rules; in the second phase they wanted to explore whether there were discrepancies 
between the websites of national and international pharmaceutical companies those 
exist in Turkey. 
The  company websites were evaluated in terms of IEIS guidelines.  The list of all 
the national and international pharmaceutical companies in Turkey was obtained 
from the Community Pharmacists’ Desk.  Each pharmaceutical company’s website 
was assessed in terms of compliance with the IEIS guidelines. Each site was 
evaluated in terms of availability of drug advertisement, mail address, e-mail 
address, telephone number, fax number, update information, indication of target 
group, links, references, information to the public, appropriate content for the 
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intended target group, disclaimer stating the given info is only for healthcare 
professionals, disclaimer stating the given information cannot replace a physician or 
a pharmacist, responsible person/ body for the website design. 
A total of 51 pharmaceutical companies were eligible for evaluation, of these 34 
(66.7%) were national and 17 (33.3%) were international. Of all the evaluated 
websites, 18 companies had advertisement on their home page. Of the total 
companies, the majority (89.2%) had mail address and telephone number; fax 
number (84.3%); information for the public (64.7%); links (66.7%); and appropriate 
content for the intended target group (only for health professionals) (62.7%). Most of 
the pharmaceutical companies did not provide an e-mail address (64.7%) on their 
website. The frequency of having update information and a seperate pharmacist/ 
physician information part was higher among international websites compared to the 
national ones.  There were more national pharmaceutical company websites (75.8%) 
than the international pharmaceutical company websites (24.2%) not providing 
information for the public, whereas the number of websites providing information to 
the public was equal for both national and international pharmaceutical companies. 
The ratio of national pharmaceutical company websites (64.7%) supplying links was 
higher than the international ones (35.3%). 
There were more national pharmaceutical company websites (69.4%) that failed to 
provide references than the international pharmaceutical company websites (30.4%). 
It is a common approach that almost all health related websites on the Internet to put 
a disclaimer stating that the provided information cannot replace a healthcare 
professional. Of the 34 national pharmaceutical company websites, 62.5% provided 
that disclaimer while of the 17 international pharmaceutical companies 37.5% had 
that disclaimer on their websites. On their websites 72.4% of the national 
pharmaceutical companies indicated the responsible person/body for designing the 
website, whereas this ratio was 27.6% for international pharmaceutical company 
websites 
As a result of the evaluation, majority of the pharmaceutical companies failed to 
comply with the guidelines set by IEIS when designing their website on the Internet. 
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The international pharmaceutical company websites were significantly better than the 
national ones in two aspects:  
Updating their websites and providing seperate pharmacist/physician information 
part as the guidelines suggested. When other criteria were considered both national 
and international pharmaceutical company websites had many missing items. Also 
important was the pharmaceutical companies’ questionable approach by putting ads 
on their main pages, which is also contrary to the drug promotion regulations in the 
country. It should be the responsibility of the pharmaceutical companies to 
communicate evidence-based scientific data in a format that can be easily understood 
by most lay persons. However, most of the pharmaceutical company websites were 
insufficient in providing information to the public. In spite of such detailed 
guidelines, pharmaceutical companies failed to comply with them.  
After the overview of the recent literature in this are, it should be noted that in this 
study, it’s important that the quality of the website should be measured from the 
physicians’ perspective. The existing  literature on the pharmaceutical website 
quality is often viewed from ethical perspective or consumer perspective, which 
arises the need to establish a new measure which incorporates the pharmaceutical 
web site quality and physician perspective. 
2.2.4 The Internet Use Among Physicians 
Internet technology has enabled health professionals to obtain and share increased 
amounts of health care information and to track and monitor diseases. In addition, the 
Internet has allowed physicians throughout the world to collaborate, communicate, 
and interact. Increasingly, physicians use on-line databases to search for the latest 
information on clinical protocols in different medical specialties and patient 
management and to consult with specialists and seek continuing medical education. 
The Internet is of increased importance in the practice of medicine as a consequence 
of the efficiency of communications, the accessibility of on-line evidence-based 
medicine reviews, and the need to assist patients in selecting reliable Internet 
resources (Chew and others, 2004).  The Web serves as a source of physician 
education and decision support. There are many opportunities on the web, like 
textbooks, journals, online courses, self-assessment examinations, alerting services, 
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email consultations to colleagues, access to clinical guidelines, and decision support 
programs. Physicians report increased use of the Web during office visits with 
patients and for continuing medical education purposes off hours. (Wald and others, 
2007)  
The core focus of this study is pharmaceutical marketing to health experts. From an 
international perspective, excluding the United States, e-marketing is clearly a 
physician-focused strategy. Due to regulatory restrictions, consumer advertising and 
online promotion are not viable options for pharmaceutical e-marketers. 
As a result of these limitations on consumer marketing, the real opportunity for 
impact lies with physicians. The data surrounding physician technology use and 
interest in online pharmaceutical information reveal significant opportunities in the 
realm of physician e-marketing strategies. 
Our understanding about the role of the Internet as a resource for physicians has 
improved in the past several years with reports of patterns for use and measures of 
impact on medical practice.  
Understanding more about physician information-seeking needs, behaviors, and uses 
is critical to CME ( Continuing Medical Education)  providers to support a self-
directed curriculum for each physician. A shift to increased use of electronic CME 
options points to new demands for users and providers. Specific information about 
how physicians create a question and search for resources is an area that requires 
providers to develop new skills. 
According to a survey released by Manhattan Research, physicians are increasingly 
turning to high technology in conducting their everyday practices. The market 
research firm reported that nearly 40 percent of the physicians surveyed have used 
iPods or another portable digital music player.  Towards the 'digitization' of health 
information, the data revealed continued growth of physicians using electronic 
medical records or electronic prescribing. According to the results, 142,000 
physicians in USA reported they are actually using the Internet during patient 
consultations. Even on the cutting edge of technology, Manhattan Research found 
that 487,000 physicians use the "new media", streaming video, downloadable audio 
content and blogs.  In their contacts with pharmaceutical companies, 75 percent of 
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physicians said they have used; or are interested in using online customer service 
with drug companies. (Manhattan Report, 2006) 
Bennett and others, (2005) have carried out a survey about Internet use and physician 
information seeking, which was administered by facsimile transmission to a random 
sample of 3,347 physicians. The results showed that almost all physicians have 
access to the Internet, and most believe it is important for patient care. The most 
frequent use is in accessing the latest research on specific topics, new information in 
a disease area, and information related to a specific patient problem. Critical to 
seeking clinical information is the credibility of the source, followed by relevance, 
unlimited access, speed, and ease of use. Electronic media are viewed as increasingly 
important sources for clinical information, with decreased use of journals and local 
continuing medical education (CME). Barriers to finding needed information include 
too much information, lack of specific information, and navigation or searching 
difficulties.  
The internet usage rate is as high as USA, in Northern Europe. (Nylenna and 
Aasland, 2001) have designed a study, based on a postal survey of a random sample 
of 1646 active physicians, totaling more than 10% of all Norwegian physicians. A 
questionnaire on Internet access and use, reading and learning habits, as well as self-
perceived ability to keep up with the medical knowledge was mailed.  
Seventy-two (72%).  percent of the respondents had Internet access either at home, at 
work, or both. Forty-eight percent of Norwegian physicians are reported using the 
Internet for professional purposes with a median of 60 minutes per week devoted to 
such activities; 54% (50-57) of male physicians and 37% (33-42) of female 
physicians used the Net actively in a medical context. Only 14% of the "Internet-
active" physicians received email from patients. Searching the World Wide Web was 
the activity most frequently reported. Research-oriented male physicians 30-49 years 
of age indicated the highest activity on the Net. Physicians using the Internet for 
professional activities reported significantly longer working hours and more time 
spent on medical reading and attending medical meetings and congresses than others.   
A research by Bard  (2006)  reveals widespread adoption of core activities such as 
visiting professional journals online, accessing information from professional 
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societies, and searching literature databases. Certain activities that have become 
widespread in the U.S. market have yet to attract a core group of international 
physician users. One key example is electronic detailing, where adoption rates 
significantly lag the U.S. market. There is substantial room for growth in this area 
due to a lack of interest, offerings, and awareness among European physicians. 
Additionally, there are considerable differences in adoption when comparing 
country-by-country trends, with Spain typically lagging behind the average adoption 
rates, while the United Kingdom leads the pack - a finding that underscores the 
necessity of localizing physician marketing efforts. For instance, the majority of 
European physicians still demand professional content online in their native 
language. That said, the data reveal a core group of key indicators surrounding 
learning and promotional preferences that can drive best practices for e-marketing 
strategies across Europe and on a global basis.  
Ken Masters (2006) has engaged in a worldwide survey to determine doctors’ 
reasons for using the Internet, and the factors that influence their usage. Because he 
was attempting to examine a global picture, and because Internet infrastructure varies 
internationally, the studies were grouped according to the region in which they had 
been conducted. For purposes of context, the percentage of doctors reporting Internet 
access is also given and compared to the national average percentages as given by 
the International Telecommunications Union (ITU). According to the results, on 
average, 60–70% of physicians had access to the Internet. On the specific use of the 
Internet, the studies offered respondents a wide range of activities from which to 
choose. In the five studies where more than 50% of the respondents found the 
Internet useful, 89% had an email account.   Some studies reported on the 
relationship between usage and demographic factors.  One study indicated a negative 
correlation on practice size, and one study indicated a negative correlation on 
generalists versus specialists. Common wisdom, perhaps based on the male/female 
ratio in Information Technology fields, would lead one to believe that males use the 
Internet far more than females. While the studies showed a slight tendency towards 
this, it is by no means clear-cut, with seven studies showing low or no correlation 
whatsoever. It is true, however, that no studies indicated a significant reverse 
correlation. There is also still a strong correlation between age and usage, with the 
younger doctors using the Internet more. Connectivity was also a pre-requisite for 
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usage, but the usage figures in the research indicated that connectivity does not 
automatically lead to usage. In most of these countries, Internet access is widespread. 
Yet, the impact of obstacles such as time, workload and effort, cost, confusion, and 
concerns of liability and confidentiality illustrated that the path to greater and 
effective use of the Internet is not merely the supply of infrastructure.  Although lack 
of skills features low on the list of barriers, in any activity, there is a natural 
relationship between skills and the effort and time taken to perform a task.   The high 
percentage (89%) of doctors reporting patients’ bringing Internet information to the 
consultation is interesting, especially when compared to the much lower percentage 
of doctors searching for patient-specific information on the Internet (44%) or 
referring their patients to web sites (20%).  An interesting connection existed 
between generalists and primary physicians as opposed to specialists. There was 
certainly a greater tendency for specialists to use the Internet more than generalists.  
Similarly, results showed doctors in smaller hospitals using the Internet more than 
doctors in larger hospitals. 
Ken Masters’ study shows a dominance of North American studies, and all but one 
of the studies are from the Northern Hemisphere. All the countries fall into a group 
defined by the ITU as “high income” with an average 2002 Internet penetration of 
44.5%. Not a single study was from a developing country. For this reason, the mean 
access cannot be taken as a global picture, but chiefly a picture of the developed 
world. The high rate of Internet usage amongst doctors compared to their national 
norms is not entirely surprising, as they point to a correlation between education 
levels and adoption and usage rates of new innovations and technologies. There is a 
fact that perhaps the most important concern is infrastructure for developing 
countries. Although infrastructure in developing the expertise required, are to be 
expected, and will need to be addressed if the Internet is to contribute to effective 
healthcare delivery.  Further consistently designed studies, particularly in developing 
countries are required to complete the picture. Countries needs to be addressed, 
efforts aimed at improving infrastructure for Internet access must be accompanied by 
efforts to overcome the other major obstacles.  
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2.2.5 The Prescribing Decision 
It is useful for this study to examine healthcare phenomena, such as physicians’ drug  
selection behaviours, as they are currently evolving in different countries and 
regions. In what sense can internet satisfy the relative needs, or turning to 
prescription behaviour, can be then understood better.   
In Turkey, the medical profession is rapidly changing. This change involves conflict 
between traditional culture and global culture, in terms of both the physician’s role in 
society and the role of market forces in healthcare. Traditionally, physicians have 
been accepted as unquestioned authorities, by their patients and themselves alike. 
Now many physicians in Turkey are becoming increasingly like hospital employees 
or independent bodies, and as such they are subject to the same influences on 
professional behaviour. (Kisa, 2006) 
The existing literature has studied the effect of marketing activities on physician’s 
choice at various levels. Most research finds the influence of marketing efforts of 
pharmaceutical firms on prescriptions to be significant. This result has been robust 
and has been found with pooled regressions (Neslin 2001), fixed-effects distributed 
lag regressions (Mizik and Jacobson 2004), log linear models (Rizzo 1999), diffusion 
models (Hahn and others, 1994), physician level choice models using aggregate data 
adjusting for endogeneity of prices (Narayanan, 2004), and physician level models 
using patient data. (Bhatia,2006) 
AcNielsen Research Company has done a research in Turkey, to determine the 
factors, influencing prescription behaviour. Although it’s a general research, it can 
give a brief idea about physician types and their prescription behaviours. For this 
research, 450 physicians, min. 2 years experienced, mostly cardiologists, who see 
minimum 50 patients a week, were surveyed. According to the research, there are 
mainly 4 factors that influence prescribing behaviour. (AcNielsen Project Innovation, 
2007) 
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Figure 2.2 :   Physician Prescribing Behaviour 
The underlying factors of these 4 main influencers are summarized below: 
Company Image: Provides value for money, innovative company, ethical company, 
strong brand, reliable company, wide product range. 
Product Profile: Effective in weak, medium and strong cases, decreasing mortality, 
efficiency, long half-life, less side effects. 
Scientific Support: Objective information about products, brochures, literature and 
journal support, samples, useful promotion materials, patient brochures, internet 
subscription, congress participation support, medical meetings. 
Sales Representatives: Ethical behaviour, regular visits, good communication, rapid 
response, long term relationship, resourcefulness, knowledgeable of the products, 
experiences, visit duration. 
According to the findings of the research, there are 4 groups of physicians. 
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Figure 2.3 :   Physician Behaviour Groups 
The largest group, “Scientific Support Seekers” has described the following factors, 
as having the largest effect on  their prescription behaviour: Long term relations of 
the sales reps, supplying medical journals and  internet subscriptions, medial 
meetings and congresses. These findings shows that different physician types show 
different reaction to the marketing efforts but this effect can not be under-
emphasized. 
(Kisa, 2006) conducted a study to identify factors that influence prescribing 
decisions among physicians in Turkey. This study is important because the factors 
that influence physicians’ prescribing behaviours are difficult to quantify and have 
rarely been acknowledged especially in Turkey. For the purpose of the study, 156 
physicians in a Ministry of Health Hospital in Ankara were surveyed. The majority 
of the participants reported that pharmaceutical representatives were their main 
source of information about new drugs on the market. Regarding peer influence on 
drug selection, 75% of the physicians reported being affected by department heads 
and colleagues in the same specialty. Generic drug issues were also important, with 
74% of the participants agreeing that for drugs having the same active ingredients, 
local versus foreign distinctions should be made to protect national interests, and 
88% completely agreeing/agreeing that the patient’s economic level and social 
security must be considered in drug selection. In addition, important concerns were 
gathered regarding ethical issues and patient drug use.  Almost all of the physicians 
(94.2% or n=147) completely agreed/ agreed that laboratory analysis results have to 
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be considered in drug selection.  On whether time required for recovery must be 
considered in drug selection, 132 physicians (84.6%) completely agreed/agreed that 
it must be considered.  It’s important that half of the physicians in this study 
completely agreed/agreed that promotional campaigns affect physicians’ drug 
selections (51.9%, n=81). Most physicians completely agreed/agreed that the 
patient’s economic level and social security must be considered in drug selection 
(87.1% or n=136). About 75% of the participants (n=116) completely agreed/agreed 
that physicians working in hospitals, when selecting drugs, are affected by 
department heads and colleagues in the same branch. Regarding drug firms’ drug 
demonstration activities, 46.8% of the physicians (n=73) agreed that the drug 
demonstration activities of drug firms are sufficiently informative. Similarly, 43.6% 
of the physicians (n=68) agreed that when a drug is being selected, attention must be 
paid to the name of the firm that produces it.  In terms of drugs having the same 
active ingredients, the majority of the participants (72.4% or n=113) completely 
agreed/agreed that local versus foreign distinctions should be made to protect 
national interests.  About 96% of the physicians (n =149) completely agreed/agreed 
that patient-drug match and drug contraindications have to be considered when 
prescribing drugs.  Two-thirds of the participants completely disagreed/disagreed 
that the concept of “expensive drugs have good quality” is true (66.9% or n=103). 
Nearly all participants (98.1% or n=153) completely agreed/agreed that ease of use 
from the patient’s perspective should be considered when selecting drugs.  About 
75% of physicians (n=116) completely disagreed/disagreed that physicians can use 
opportunities provided by drug companies when they prescribe a particular drug, and 
that this can be considered ethical under current economic conditions.  On the 
question of setting aside enough time for drug selection, two-thirds of the physicians 
completely agreed/agreed that they do so even when patient duties are intense 
(67.3% or n=105). Nearly all participants completely agreed/agreed that they obtain 
and use new information from a scientific perspective in drug selection (96% or 
n=149).   Half of the physicians (50% or n=78) completely agreed/agreed that 
continuing education programs organized by professional medical organizations 
contribute importantly in keeping physicians informed about developments in the 
pharmaceutical sector.  Two-thirds of the physicians completely disagreed/disagreed 
that sufficient scientific information and guidance on other points requiring attention 
when prescribing drugs are provided to medical students during their education (66% 
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or n=103).  As can be seen in the findings, the effect of promotional activities, on 
prescribing behaviour are still regarded as an intimate issue, because it has the risk of 
being confused with the ethical problems. However, this is not really based on very 
rational support, because there are equivalent remedies among which doctors have 
the right to choose from. The “ethics” can be questioned of course, if a doctor 
chooses a medication on top of the other, although it’s not the best decision to make, 
but supports his own benefits. 
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3. CONCEPTUAL MODEL 
The core focus of this study is pharmaceutical marketing to health experts. From an 
international perspective, excluding the United States, e-marketing is clearly a 
physician-focused strategy. Due to regulatory restrictions, consumer advertising and 
online promotion are not viable options for pharmaceutical e-marketers. 
As a result of these limitations on consumer marketing, the real opportunity for 
impact lies with physicians.  
Internet technology has enabled health professionals to obtain and share increased 
amounts of health care information and to track and monitor diseases. In addition, the 
Internet has allowed physicians throughout the world to collaborate, communicate, 
and interact. (Chew and others, 2004). The Web serves as a source of physician 
education and decision support. There are many opportunities on the web, like 
textbooks, journals, online courses, self-assessment examinations, alerting services, 
email consultations to colleagues, access to clinical guidelines, and decision support 
programs. Physicians report increased use of the Web during office visits with 
patients and for continuing medical education purposes off hours. (Wald and others, 
2007)  This great database is of course most widely sourced by commercial 
pharmaceutical drug companies. 
The existing literature has studied the effect of marketing activities on physician’s 
choice at various levels. Most research finds the influence of marketing efforts of 
pharmaceutical firms on prescriptions to be significant. 
Buckley (2004) has underscored the internet sources of drug companies, in the 
context of marketing. He described the drug marketing process, by the model below 
in Figure 3.1, which shows the information flow from drug companies, both to 
consumers and doctors. It also shows the power that consumers, informed by DTCA 
and the Internet, have in “pulling” prescription drugs from doctors. In Turkey, DTCA 
is banned, but internet continues to affect doctors directly, and also indirectly, 
35 
through consumers. However, the influence of consumers’ opinions on doctors is not 
within the scope of this study. The main area of interest is the relationship indicated 
with the red arrows, the influence of drug companies on doctors, through internet. 
Figure 3.1 :   The Information Flow in Pharmaceutical Marketing 
Our model is about the red arrowed line of Buckley’s model and it aims to define the 
value that internet based activities of drug companies contribute to. The main aim of 
undertaking the cost associated with internet activities can of course be defined by 
several reasons like scientific support, increasing physician expertise etc.. but it 
would not be wrong to state that the main objective is increasing profits, and that is, 
increasing the number of prescriptions by the physicians. Whether these efforts help 
to increase the prescriptions is an important question to know, because marketers are 
being held accountable for their budget allocations as measured by the number of 
new prescriptions. But whether internet costs contibute to these efforts work or not, 
is still in question. Based on such a sense, our model is built to firstly understand the 
expectations of physicians from the online sources of the pharmaceutical companies, 
and further clarify the effects of online marketing efforts of pharmaceutical 
companies, on the prescription behaviours of physicians. 
Our model states that the website quality  of a pharmaceutical company has positive 
effect on the prescription behaviours of the physicians that visit this company’s 
website. This effect on the prescription behaviour could be explained by various 
factors, but the main effect comes both directly from the web site and also through 
increasing the company’s image.  
Drug Companies 
Sales reps, gifts, 
conferences, 
etc.. 
      Internet Direct to Consumer 
Advertising 
    DOCTORS    Consumers 
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Figure 3.2:   Conceptual Model 
This perceived quality (impression) as this study assumes, has a direct effect on the 
prescription behaviours of the physicians. It also assumes that the perceived quality 
also has effects on  increasing the pharmaceutical company’s image. And 
company/brand image, as the literature shows, has direct positive effect on the 
prescription behaviour. 
In this model, “the perceived website quality” is very imporant to determine. 
Because quality is a relative concept. Quality is defined as “the totality of 
characteristics of an entity that bear on its ability to satisfy stated and implied needs.” 
(Bell and Tang, 1998) For quality to be evaluated, these needs have to be defined and 
translated into a set of quantitatively or qualitatively stated requirements for the 
characteristics of an entity that reflect the stated and implied needs.  (Aladwania and 
Palviab, 2001) For these reasons, we have to define the website quality concept for 
physicians who use internet.   
Liu and Arnett (2000) named such quality factors as accuracy, completeness, 
relevancy, security, reliability, customization, interactivity, ease of use, speed, search 
functionality, and organization. Huizingh (2000) focused on two aspects of web 
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quality: content and design. Wan (2000) divided web quality attributes into four 
categories: information, friendliness, responsiveness, and reliability. The authors 
highlighted the importance of factors such as download speed, web interface, search 
functionality, measurement of web success, security, and Internet standards.  Kim 
and Others(2006) defined perceived web quality as users’ evaluation of a web site’s 
features meeting users’ needs and reflecting overall excellence of the web site and 
identified three dimensions of web quality: technical adequacy, web content, and 
web appearance. Our model harmonizes these dimensions into 3 main criteria: 
Content, Navigation and Innovativeness. Kim and others’ study is similar for these 3 
aspects. We also add objectivity as the last criterion, an indispensable indicator of a 
pharmaceutical information quality.  
Most importantly, in this study it’s assumed that a physician’s idea about a positive 
aspect of a website does not necessarily mean that it creates a value for the physician. 
For example a physician might think that the design was really good in a website, but 
this does not have a significant meaning for him, because design is not an important 
factor in assessing the quality of a website, according to him.  
In this study, it’s important that the quality of the website should be measured from 
the physicians’ perspective. Existing literature on the pharmaceutical website quality 
is often viewed from ethical perspective or consumer perspective, which arises the 
need to establish a new measure which incorporates the pharmaceutical web site 
quality and physician perspective. That’s why, we researched both the main 
characteristics of the site and also what the physician expects from that site. This 
adds a new moderating variable to the model, which is the “expectations of the 
physicians from the website” 
The performance of the website, together with the moderating effect of the 
expectations of the physicians, forms the “perceived quality” of that site. 
Based on these assumptions, our first set of hypothesis are as follows: 
H1: The more positively physicians perceive the quality of a pharmaceutical 
company website, the more likely they are to form a positive image of that company 
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H1a: The more positively physicians perceive the content of a pharmaceutical 
company website; the more likely they are to form a positive image of that 
company 
 
H1b: The more positively physicians perceive the navigation of a 
pharmaceutical company website; the more likely they are to form a positive 
image of that company 
 
H1c: The more positively physicians perceive the innovativeness of a 
pharmaceutical company website; the more likely they are to form a positive 
image of that company 
 
H1d: The more positively physicians perceive the objectivity of a 
pharmaceutical company website; the more likely they are to form a positive 
image of that company 
At the beginning of 1990s some corporate executives predicted that web sites will be 
capable of influencing companies’ image significantly (Dyson, 1997). In today’s e-
business environment this influence is becoming evident, forcing companies all over 
the world to pay attention to web site features and making company’s web image the 
focus of major corporations and their executives in particular (Jon, 2001). More and 
more companies are aware that the web site design is becoming a very important 
issue for them (Agarwal and Venkatesh, 2002) 
Some authors are of the opinion that competitive advantage is just another benefit 
that can be achieved by paying considerable attention and having a well designed 
web site. Recently, however, the focus of many corporations is on facilitating more 
effective transformations to the web-enabled business environments, and the 
importance of improving users’ experiences is becoming widely evidenced. 
Furthermore, as web sites represent companies’ interface with the customers, the 
quality of the web sites and presence of particular features is crucial for bringing in 
the benefits. (Kuzic and others, 2005) 
Content of the web site can determine whether the potential customer will stay on the 
web site or never to be seen again (Gehrke and Turban, 1999) 
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Many companies are aware that a well defined content of the web site can contribute 
to the building of a good brand image. The direct effect of perceived website quality 
on the image of the pharmaceutical company comes from that, innovativeness has 
been advanced as an essential image characteristic in terms of marketing 
effectiveness. Companies with an innovative image are typically associated with 
unique marketing programs, R&D-oriented and being modern and up-to-date. There 
is sample evidence that innovative companies are perceived in more favourable terms 
than non-innovative firms in terms of credibility and expertise, perceived quality, 
purchase likelihood and market share size. (Ruyter and Wetzels, 2000) 
Apart from innovativeness, a pharmaceutical company can strengthen its image 
through internet, by many opportunities. Neadle (1964)’s model defined the qualities 
that construct the image of a pharmaceutical firm. At the end of the research he 
demonstrated that the image of a pharmaceutical corporation has a direct bearing on 
behaviour toward the corporation or its products. In his scale, there are various 
dimensions which can be strengthened via internet. 
Product Image: Its products are of consistently high quality, Has good drugs in many 
different product areas, Its products are reasonably priced 
Service Image: It keeps physicians adequately informed about its products, Has been 
a real help to the medical profession, Helps practicing physicians keep up to date on 
medical developments, It is interested in serving the practicing physicians, not just in 
promoting its products, It is interested in serving the public, not just in making 
money 
Detailing Image: Its detail men are well informed and helpful, Has high calibre detail 
men 
Advertising Image: Its advertising and promotion to physicians are dignified and 
restrained, You can believe what it says about its products, It presents adequately the 
side effects and contraindications, as well as the advantages of its products, Its 
product claims are consistent with broad clinical evidence 
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Research Image: Its research has produced products of major significance, A leader 
in research, Outstanding on new product development, Outstanding on clinical 
investigation, Very good on finding new uses for existing products 
Miscellaneous: Has real integrity, A rapidly growing company, It's pleasant to do 
business with them, Known for high calibre management 
As can be seen, there are factors other than innovation that can be communicated via 
internet  
 
The second hypothesis in our model is described below: 
 
H2: The more positively physicians perceive the image of a company; the more 
likely they are to prescribe that company’s products. 
In fact, it has long been recognized that the brand name is the dominant cue in 
decision making by many consumers. A brand provides identification and continuity 
in the marketplace and is the most visible extrinsic cue to the consumer.  Corporate 
image represents a powerful link to brand image and purchasing behaviour (Hsieh 
and others, 2004). Defined as consumer’s attitudes toward a company, corporate 
image can create new beliefs about a firm, which in turn influence attitudes toward 
products and product preferences (Homer, 1990; Simmons and Lynch, 1991). 
Corporate image not only adds value but also creates a halo effect for all of a 
company’s products (Hsieh and others, 2004). In the context of counterfeits, the 
corporate image of original manufacturers versus counterfeiters plays an important 
role. Buying counterfeits may be considered hazardous, as the risks incurred are 
manifold, ranging from financial, performance, and physical, to psychological and 
social risks (Tan, 2002). To reduce these risks, consumers are likely to rely on 
information about the trustworthiness of a company (Gürhan and others, 2004).  
Richard and Van Horn (2004) suggested that brand names may have some direct 
influence on prescription choices of medical specialists, even among drugs that are 
therapeutically and therefore perhaps chemically the same. Research by Gonul and 
others (2001) also suggests that marketing activities and expenditure, and therefore 
brand name, may also influence prescription choices. Other research by Pincus 
(2004) suggests that the introduction of cheaper, chemically equivalent generics, in 
this case generics, only marginally changed the market share, by less than 1 percent 
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of all established branded products in this category, such as Prozac. This indicates 
the importance of brand name in repeat purchasing perhaps especially for new or 
innovative pharmaceutical products. Blanckett and Robins (2001) have underscored 
the importance of branding in the pharmaceutical industry. Their book endeavours to 
comment on all the major trends and provide some advice on how brands and the 
branding process can be made integral to future business strategy. They examine the 
chief drivers of change, in particular the internet and the growth of direct-to-
consumer advertising; government policy; the ageing population; the prescription to 
OTC ‘switch’; and trends in communication and brand building, together with the 
complex regulatory frameworks that circumscribe these. But throughout they have 
tried to focus on the value-adding contribution that strong brands can make to 
corporate performance.  They have found that each pharmaceutical brand has now 
become so well known that it stands for a set of distinctive characteristics and 
benefits, the net impact of which is the belief on the part of prescribers, pharmacists 
and consumers that the brand is superior to imitations. In a competitive situation this 
belief may not be strong enough to justify paying more, but given parity – or near-
parity – in price then the tried and trusted brand will usually enjoy an advantage. A 
strong image and brand, therefore, has the ability to command reliable cash flows. 
The 3rd set of hypothesis is as follows: 
 
H3: The more positively physicians perceive the quality of a pharmaceutical 
company website; the more likely they are to prescribe that company’s products. 
H3a: The more positively physicians perceive the content of a pharmaceutical 
company website; the more likely they are to prescribe that company’s 
products. 
H3b: The more positively physicians perceive the design of a pharmaceutical 
company website; the more likely they are to prescribe that company’s 
products. 
H3c: The more positively physicians perceive the innovativeness of a 
pharmaceutical company website; the more likely they are to prescribe that 
company’s products. 
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H3d: The more positively physicians perceive the objectivity of a 
pharmaceutical company website; the more likely they are to prescribe that 
company’s products. 
There is not much literature research that studies on a direct relationship between  
pharmaceutical website performances but several studies have qualitatively 
explained a relationship.  
Cutts and Tett (2003) have stated that continuing medical education is known to 
influence prescribing and this statement is most likely to be met at easier access to 
information through information technology (Internet and computer prescribing 
packages)  
Buckley (2004) has underscored the internet sources of drug companies, in the 
context of marketing. He stated that internet continues to affect doctors’ prescription 
behaviours directly, and also indirectly, through consumers. 
Our study will make its greatest contribution to the literature by clarifying the 
relationship between the website quality of a pharmaceutical company and direct 
effect of it on the prescription behaviours of the physicians that visit this company’s 
website.
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4. MODEL TESTING 
4.1 Country Backround: Turkey 
Our study is mostly conducted in Turkey. Therefore, it would be useful to have a 
quick overview at the recent history of pharmaceutical sector in Turkey. 
During the early Ottoman period drugs were generally prepared by physicians. 
Rooms called Hekim Dükkani (Physicians Store) functioned as drugs preparatory 
locations as well as treatment centers.  
With widely use and increasing importance of medical preparations among 
physicians, pharmacists and  the public, new drug compounds were prepared in 
pharmacies or laboratories  
The first local drug preparations, formulated either in pharmacy laboratories or small 
workshops during the Pharmacy period, covering the period between 1833 and 1927, 
were prepared as mere imitations of imported and high-selling drug preparations. 
After a while the commonly used formulas by the renowned physicians of the time 
were prepared at  pharmacies and presented to patients.  
The number of local drug preparations in Turkey in 1930 was about 300, most of 
which were prepared at pharmacies while 20 of them at laboratories. What brought 
the end of small local pharmacies was The Foreign Capital Incentive Law enforced 
in 1954 paving the way for giant foreign pharmaceutical companies to come to our 
country to establish drug production factories, which coupled with the enforcement 
of  The Pharmacies and Medical Preparations Laboratories Regulations dated 1954, 
which brought heavy financial responsibilities to the companies in question when 
they established factories and production facilities. Furthermore, the law required the 
allocation of a separate building for drug production. The mentioned points were 
mainly legislated with the entrance of foreign companies to the market, but caused 
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some small initiatives to get out of business and others to merge with foreign 
companies, thus maintaining their existence. (Uvey and others, 2004) 
The Fabricated drug production in Turkey is a relatively recent period, started in 
1952 with the establishment of  Eczacıbaşı İlaç Fabrikası (Eczacibasi Pharmaceutical 
Factory) in Levent, Istanbul. With the requirement of regulations, many small local 
companies moved into their separate facilities, which they built with great effort, 
undertaking great financial difficulties, renewing their techniques and merging with 
foreign companies, thus keeping pace with the latest trend, that is, serial production. 
As a result of these developments, the all-local pharmaceutical preparations 
formulized by Turkish pharmacists were gradually left aside and foreign preparations 
were started to be produced (Abdi İbrahim, Eczacıbaşı, İbrahim Ethem, Fako, 
Mustafa Nevzat). While local firms maintained producing foreign products under 
license agreements, some foreign-based firms (Roche, Bayer, Sandoz etc.) started to 
produce at their own facilities. Harmonizing the accumulation of knowledge and 
experience gathered during the previous pharmacy-laboratory periods, the Turkish 
pharmaceutical industry, especially as of 1990, managed to improve itself by keeping 
pace with the latest technology and world standards.The golden period of the Turkish 
pharmaceutical sector started with the foundation of the Employers Union of 
Pharmaceutical Industry in 1964, aiming at moving in unison to be successful at  
world standards (Baytop, 2000)  
Today, in 2007, according to the data from IMS (International Medical Statistics);  
There are 320 companies operating  in the Turkish pharmaceutical industry;  
• 96 pharmaceutical manufacturers  
• 52 foreign companies 
• 23.000 employees 
• Over 5000 products 
12 out of 52 companies operating with foreign capital have their own production 
facilities in Turkey. The others put their products in the market either through 
importing or fason production  (UEIDC report, 2000) 
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In 2007, drug sale at the value of $7  billion was realized in Turkey.  According to 
the data belonging to 2007 regarding the treatment groups: antibiotics ranks first with 
19%, painkillers second with 15%, drugs for cold, rheumatism drugs and vitamins 
rank next.  (Seyhan,2006) 
The Turkish pharmaceutical industry has acquired a level of quality, activity and 
trust so as to compete with many countries operating in the sector. In 1999 the export 
figures of the sector amounted to more than 50 countries including Germany, U.S.A, 
Belgium, Finland, Holland, England, Switzerland, Italy and Japan. However, the 
problems arising from the pricing system of Turkey, high level of Value Added Tax 
(VAT) rates, the drawbacks emerged in recent years have prevented the sector to 
obtain a high level of profit margin. (Uvey and others, 2004) Turkey's per capita 
pharmaceutical expenditure - the lowest in Europe - is still approximately USD 50. 
This is due to economic and cultural constraints, compared with Western countries. 
In spite of these challanges, Turkey's total pharmaceutical production makes it 16th 
among the world's 35 leading pharmaceutical producing countries. It is the largest 
pharma market in the Middle East, and the fastest growing in the Mediterranean 
region. (Yesildere,2008) 
It can be suggested that government control and regulations are strict, because the 
majority (approximately 70–80 percent) of drug purchases throughout the country 
are reimbursable through public sector agencies such as the Pension Fund and the 
Social Insurance Organization. (Kısa, 2006). That, at the same time  means that the 
majority of sales are dependent upon prescription.  
In Turkey, there’s no concept as OTC. This means that according to the legislation, 
all drugs must be bought with a prescription. And DTC  of pharmaceuticals is illegal. 
The advertisement of prescription drugs to the public was prohibited in Turkey in 
accordance to the law passed in 1928 and 1994. According to the law of The 
Foundations and Broadcasts of the Radio and Television which was put into effect in 
1994, advertising for the non-prescribed drugs was allowed on the condition that it 
met the following criteria, if they are open, reflecting the facts and can be verified, 
and protects the individual from harm.  In 1996, The Ministry of Health declared that 
drugs be classified as prescribed or non-prescribed. Since then, several attempts have 
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been made by the Ministry of Health to allow drug advertising for non-prescribed 
drugs. However, other state organizations such as the Council of State have come out 
in opposition to this. As can be seen, while the non-prescribed drugs can be actually 
legally advertised, all drugs belong to prescription drugs category in Turkey and they 
can not be promoted to patients. (Semin and others, 2006)   
The online health information search of patients, and whether they demand a 
particular brand from their doctors as a result of this search can not be under-
emphasized, however it will stay out of focus of this study, since the pharmaceutical 
companies’ efforts toward consumer advertising is actually illegal. However a further 
research is needed to examine the online behaviours of patients and their effects. 
4.2 Methods 
As stated before, this study is mainly based on understanding the value of the online 
marketing efforts of pharmaceutical companies and also helping pharmaceutical 
companies to better align their online marketing efforts with the expectations of the 
physicians. This model states that the website quality of a pharmaceutical company 
has positive effect on the prescription behaviours of the physicians that visit this 
company’s website. This effect on the prescription behaviour could be explained by 
various factors, but the main effect comes both directly from the web site and also 
through increasing the company’s image.  
Although there is previous research on the related subjects, this study involved a 
previous exploratory research, because of both the sensitive nature of the concept and 
also the great variability in different countries. The development of hypothesis 
required consultation of both physicians and pharmaceutical experts. There had to be 
a balance between marketing point of view and physician point of view, in the 
development of the hypothesis. Before interviewing with physicians, in-depth 
questions had to be conducted with experienced health-care experts, in order to 
understand how to tap information from physicians better. After having an insight of 
the concepts of pharmaceutical online marketing, prescription behaviours, DTP 
advertising etc… With the help of literature and the in-depth interviews; attention 
was drawn to physicians. First, unstructured, later structured in-depth interviews 
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were conducted with them. Their input also helped the development of 20 survey 
questionnaire, which measured totally 62 items. Responses were recorded through 
the use of open questions and a Likert type scale, and then analyzed for the testing of 
the hypothesis. 
4.3 In-Depth Interviews 
When literature was studied about the related subjects, unstructured interviews were 
conducted with healthcare industry experts (Pharmaceutical Company Sales and 
Marketing Managers) and physicians. The objective of these unstructured interviews 
were to cause some preliminary issues to surface so that it would be known which 
issues need further investigation. That gave a grip on the variables that need greater 
focus, so that they were used in the structured in-depth interviews.  
Structured In-depth interviews were conducted face to face with 18 physicians, from 
7 different cities in Turkey. Face to face method was used, because establishing some 
rapport was important in gaining the trust of the interviewees.  11 of them (%61) 
were specialists, and 7(%39) were practitioners. 15 (%83) were seeing patients on a 
regular basis. The aim was both forming a basis for the questionnaire, and also 
identifying the responses, -and motivation of responses- of physicians. All interviews 
were made with physicians, who were active internet users. An audiotape was not 
used to record the answers, and notes were taken, because of the sensitive nature of 
the concept. It might have biased the respondent’s answers, who could suspect that 
their anonymity was not completely preserved.. 
The concepts sought were as the following: 
Name, specialisation, age, organization, the number of patients in a week: These 
were collected on basic descriptive assumptions, which will be examined in more 
detail on the survey.  
The intensity and reasons of internet usage: This gave estimation on how to group 
the intensity and objectives of physician internet usage. The question was not 
directed by listing the reasons, but rather listening from the physicians about their 
main internet usage reasons. The majority (%78) told that searching for medical 
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information was their chief reason for using internet. The other reasons include e-
mailing, reading the news, being up to date with the innovations. 
The independent web sites: The physicians were questioned for their usage frequency 
and usage intensity of independent health web sites. Surprisingly, many physicians 
reported using the same well-known website (%55) and even more surprisingly, %82 
of users reported visiting their favourite site more often than once a week. The most 
favourable section of websites was “diagnosis” section, reported by %43. 
The pharmaceutical company web sites: The answers to this question were generally 
very different from each other. The most popular web site here had a hit of only % 
22. The intensity decreased a little here. %66 of physicians visited their favourite 
pharmaceutical company website more than once a week. Their favourite section is 
“Medical Journals”, with %50. 
The quality of Pharmaceutical company websites: The physicians were generally 
pleased to see the advancements on internet in the last years, but were still sceptical 
about the objectivity of drug company websites. Some of them stated that the failure 
of objectivity in medical information can be a great turn-off for physicians, and this 
is even worse than supplying no scientific support at all. Because in time, this 
attitude causes a mistrust for the company, which is a very important part of a 
pharmaceutical company image.  
Pharmaceutical website quality dimensions: The pharmaceutical website quality 
dimensions were questioned and to form an objective and comparable basis, and they 
were recorded on a Likert scale. The main qualities complied with what our 
conceptual model had assumed. However there were some sub-factors which were 
reported almost of no importance. This resulted in the elimination of some measures 
which were classified as “not very important” and “not important at all” by more 
than %90 of the physicians. Some examples include, “increasing the communication 
between patients and physicians.” and “fast opening of the pages”. These were not 
included later in the questionnaire 
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4.4 Survey 
A cross-sectional study amongst medical doctors was conducted. A questionnaire 
was developed to test the hypothesis and it was prepared in Turkish. 
The questionnaire was sent with an e-mail to nearly 300 physicians (from physician 
e-mail lists) and returned with a response rate of %46(140 responses).  85 physicians 
completed the survey by being handed out and returning immediately. 23 were 
interviewed on telephone. The reason of the difference in the methods used was 
mainly the great number of different people that had to be reached during a short 
period of time. Since our questions only had to be sent to physicians who were using 
internet, it was hard to obtain the contact information of such a specific group.  
It was assumed that the returned questionnaire forms, which were used as data 
sources, contained honest responses. It was also assumed that the study participants 
accurately represented their group as a whole, within identified limitations. The 
participants of the study were informed about the confidentiality of their participation 
and responses, and were assured that the results would not be used for purposes other 
than those of the study. Also, some participants would like to see the results and were 
assured that this study would be published in a web page (www.pelinyilmaz.com) 
where they will be able to download later.  
4.4.1 The Questionnaire Design 
The 62-item questionnaire assessed baseline demographic data including gender, age, 
medical speciality, organization and questions concerning duration and frequency of 
internet usage, the importance of each website quality dimension, the last 
pharmaceutical company website visited, the performance of that website, the image 
of that pharmaceutical company which had prepared the site and  the prescription 
behaviour towards that company. The questionnaire comprised two sets of items. The 
first set evaluated actual use of the Internet and attitudes toward website dimensions 
and last visited website. The second set concerned the image of the company and the 
prescription behaviour toward that company. Questions were presented as open-
ended, grouped or Likert scales: generally 1 (very positive) to 5 (very negative).  The 
questionnaire was pilot-tested and finalised with the approval of 5 physicians. 
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The questionnaire was designed to capture sincere answers where physicians are 
aware of the ethical marketing practices. This was made clear in the instruction part 
of the questionnaire, in which the purpose of the research was briefly given. Pretests 
and in-depth interviews had confirmed that respondents had a good understanding of 
the phenomenon.  The questionnaire is attached in Appendix B.  
The questionnaire began with a selective question, which enabled the respondents to 
continue answering, only if they have visited a pharmaceutical company website in 
the last 3 months. However, this was usually asked vocally before handing out the 
questionnaire, both to save time and printed documents. Then, using the general 
durations and frequencies for obtaining a mean, physicians were first questioned 
about the duration and frequency of internet usage, using a Likert scale.  Later, they 
were asked to evaluate several website performance dimensions, including the items 
associated with content, design, innovation and objectivity, which are the 
pharmaceutical web site performance criteria outlined earlier in section 3. A 5 five-
point Likert scale was used.  (1: definitely inadequate; 5: definitely adequate) 
Then they were asked to write down or think about the last pharmaceutical website 
that they had visited. To protect the anonymity and get honest and sincere answers, it 
was indicated that they don’t have to write down the company, only remember it for 
the following questions. This gained a totally new approach by the physicians and 
increased the trust that this research was really only for academic purposes. Later 
they were asked to evaluate the last pharmaceutical web site they visited in the past 
six months, using the same performance criteria. Again the same Likert scale was 
used.  (1: definitely inadequate; 5: definitely adequate)  
The following section consisted of 9 questions designed to assess the image of that 
pharmaceutical company (6 items) and the physician prescription behaviour for that 
company.(3 items) to the degree to which physicians gave a self-reported answer that 
reflected their beliefs and behaviours. A 5 point Likert scale was used.  (1:  strongly 
agree; 5: strongly disagree). The image dimensions were: “Positive image of the 
company”, “Trusting to the company”, “Respecting the company”, “General idea of 
the company”, “People’s general idea of the company”, “Comparison with the other 
pharmaceutical companies.” These were questioned and to form an objective and 
comparable basis, and they were recorded on a Likert scale.  The prescription 
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behaviour for the pharmaceutical company image dimensions were questioned via 3 
items. The questions were: “I think this company is preferred for prescription”, “If 
under my speciality, I would prescribe its products”, and “If under my speciality, I 
would recommend this company to others for prescription.”  
An additional section pertaining to the demographic characteristics was also included 
in the survey instrument. (age, gender, city, specialty, working organization, number 
of patients in a week.) These were all open-ended questions, which were coded and 
grouped later. 
4.4.2 Sampling 
Our sample consists of 242 Turkish physicians, who are either specialists or 
practitioners, and who are active internet users. Judgemental sampling method had to 
be used for this research, because there were a limited number of people who could 
provide answers to this research. It required special effort to gain access to the 
physicians, who were in the best position to provide the answers. There are several 
physician web communities and mailing groups on the internet. Mail addresses were 
obtained from these groups, which contain various specialities and also geographical 
coverage.  Thereby, physicians could be reached across the country. Telephone-
interviews also provided the same geographical coverage. Face-to face interviews 
were mostly conducted in İstanbul, however there were still physicians from 
different cities. 
Although the sample was chosen largely according to the availability of reputation 
data, still vast effort vas placed on gaining a country-wide representative group, not 
only the most developed cities. However, due to the technological nature of the 
study, internet user physicians are resident largely in big cities. The high rate of 
Internet usage amongst doctors compared to their regions is not entirely surprising, 
The residents of the respondents were 31 different cities of Turkey. They were from 
25 different specialities. Gender was represented equally in the sample as a whole. 
However, slightly more males were included in the sample, due to the general 
characteristics of the population studied.  
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4.4.3 Findings 
A total of 240 doctors completed the survey. Collected data were transferred to a 
computer running SPSS 16.0 and general frequencies and descriptive statistics were 
used to get the feel for the data. 
Participants were from 31 different cities and 7 different regions.  Marmara,  İç 
Anadolu and Ege were the geographic regions with the highest percentages of 
respondents. There can be seen a significant tendency that the majority of the 
respondents comes from developed regions, both due to the convenience of the 
regions, and also the difference in internet usage. The ages of the physicians were 
mostly between 31 and 50 (%69). Gender was represented equally in the sample as a 
whole. However, more males were included in the sample, due to the general 
characteristics of the population studied.  
Doctor participants identified their specialty area as orthopaedics (%18,2), followed 
by practitioners (%12,8). There were no statistically significant differences found 
between specialities with respect to geographic distribution. Doctor participants  
The organization that they worked at was reported as private hospital (%26,4), 
governmental hospital (%26), private office ( %16,5), clinic (%9,5), policlinic 
(%7,4). %14 of the respondents didn’t belong to any of these groups.  
They were asked about the frequency and duration of their pharmaceutical company 
website usage. The most common responses were “once in two weeks” and “once a 
month”  (%31,4 and %30,6 respectively). Given as the answer to the usage duration, 
the most common responses were “3-4 hours per month” and “5-6 hours per month”  
(%31,4 and %23,6 respectively).  
The results of the output are shown in Table 4.1 
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Table 4.1: The Simple Frequency Distribution of the Answers 
  Count Column N % 
21 – 30 9 3,7% 
31 – 40 88 36,5% 
41 – 50 79 32,8% 
51 – 60 56 23,2% 
Yaş (Binned) / Age 
Groups 
61+ 
 
9 3,7% 
Akdeniz 25 10,3% 
Doğu Anadolu 4 1,7% 
Ege 30 12,4% 
Güneydoğu An 5 2,1% 
İç Anadolu 50 20,7% 
Karadeniz 16 6,6% 
Bölge / Region 
Marmara 
 
108 44,6% 
erkek / male 
 
172 71,1% Cinsiyet / Gender 
Kadın / female 
 
 
70 28,9% 
Özel Hastane / Private Hospital 
 
64 26,4% 
Devlet Hastanesi / Governmental 
Hospital 
 
63 26,0% 
Özel Muayenehane / Private Office 
 
40 16,5% 
Sağlık Ocağı / District Clinic 
 
23 9,5% 
Poliklinik / Policlinic 
 
18 7,4% 
Çalışılan Kurum / 
Organization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diğer / Other 
 
34 14,0% 
55 
Anestezi 2 ,8% 
Biyokimya 5 2,1% 
Biyoloji 1 ,4% 
Cerrahi 9 3,7% 
Dermotoloji 15 6,2% 
Gastroentreloji 14 5,8% 
göğüs hastalıkları 16 6,6% 
iç hastalıkları 4 1,7% 
Immünoloji 3 1,2% 
Jinekoloji 12 5,0% 
kalp-damar cerr 3 1,2% 
Kardiyoloji 13 5,4% 
kbb (kulak-burun-boğaz) 20 8,3% 
Nöroloji 2 ,8% 
Onkoloji 10 4,1% 
Ordopedi 44 18,2% 
Patoloji 3 1,2% 
Pedagoji 16 6,6% 
Pratisyen 31 12,8% 
Romatoloji 5 2,1% 
 Uzmanlık / Speciality 
Üroloji 14 5,8% 
<= 0 20 8,3% 
1 – 40 83 34,3% 
41 – 80 107 44,2% 
81 – 120 29 12,0% 
Bir haftadaki hasta 
sayısı (Binned) / 
Patients per week 
121+ 3 1,2% 
3 ayda bir kez veya daha seyrek / 
Once in 3 months or more seldom 
1 ,4% 
2 ayda bir kez / Once in 2 months 38 15,7% 
Ayda bir kez / Once a month 74 30,6% 
2 haftada bir kez / Once in 2 weeks 76 31,4% 
Haftada bir kez /Once a week 37 15,3% 
İnternet Kullanım 
Sıklığı / Internet 
Usage Frequency 
Haftada birkaç kez / More than once 
a week 
16 6,6% 
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The items, measuring the importance of the website performance dimensions for 
physicians, were all measured on a five point Likert Scale. The results are displayed 
in descending order. “Compliance with ethics” is the most valued quality, with a 
mean of 4,36. The minimum value of 3 indicates that there is not any physicians who 
considers ethics as “not very important” or not important at all”. “Objectivity of 
information” ranks as the second, with a mean value of 4,08. “Providing access to 
journals” has a mean value of 3,90, and is followed by “Currency of information”, 
which has a same mean value with “Wide medical database”. It’s surprising that 
“Customized service, a criteria that is not gained great acceptance, is valued with a 
mean of 3,72. Also, the variance is the highest for this item. It seems that there are 
two groups of physicians, one of which have discovered the utilization of customized 
service. “Easy understanding”, “Fast navigation”, “Total attractiveness” and “a Good 
organization”, which seems to very similar criteria, are ranked respectively: ( 3,58, 
3,57, 3,55, 3.55). “Multimedia applications” have a mean value of 3,50, maybe rather 
low because of the lack of insight on what could be done using multimedia. 
Multimedia is still perceived as a quality, merely regarding design. Information about 
the chemistry of drugs and about the pharmaceutical company seems to be not highly 
important, with values of 3,55 and 3,20. The less important factor for the quality of a 
website seems like “Facilitating the information among physicians”, with a mean 
value of 3,12. The output is shown in table 4.2 below. 
Table 4.2: Descriptive Statistics of “Website Performance Criteria” 
 
Descriptive Statistics 
 
N Minimum Maximum Mean 
Std. 
Deviation Variance 
Önem: Etik kurallara uyması / 
Importance:Compliance with ethics 
242 3 5 4,36 ,624 ,389 
Önem: Bilgilerin Tarafsızlığı / Importance: 
Objectivity of Information 
242 2 5 4,08 ,718 ,516 
Önem: Makalelere ulaşım sağlaması / 
Importance: Providing access to Journals 
242 2 5 3,90 ,786 ,617 
Önem: Verilen bilgilerin güncelliği / 
Importance:Currency of Information 
242 2 5 3,86 ,713 ,508 
Önem: Geniş bir Medikal Veritabanı / 
Importance: Wide Medical Database 
242 2 5 3,86 ,741 ,550 
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Önem: Özel hizmet verilmesi / Importance: 
Customized Service 
242 1 5 3,72 ,890 ,792 
Önem: Web sitesinin Kolay Anlaşılır Olması / 
Importance: Easy to be understood  
242 2 5 3,58 ,708 ,501 
Önem: Web sitesinin bütün olarak göze cazip 
görünmesi / Importance:Total attractiveness 
242 1 5 3,57 ,744 ,554 
Önem: Aranan bilgiye hızlı ulaşılabilmesi / 
Importance: Fast navigation to information 
242 2 5 3,55 ,687 ,472 
Önem: Site düzeninin iyi olması /  
Importance: A good organization of the 
website  
242 2 5 3,55 ,711 ,505 
Önem: İlaçların içeriği ile ilgili detaylı bilgi 
olmasi / Importance: Information about Drug 
Chemistries 
242 1 5 3,55 ,767 ,588 
Önem: Multimedya uygulamalar ile ilginç hale 
getirilmiş olması / Importance:Multimedia 
Applications 
242 2 5 3,50 ,758 ,575 
Önem: İlaç firması ile ilgili detaylı bilgi 
içermesi /  Importance: Information about the 
Drug Company 
242 1 5 3,20 ,870 ,757 
Önem: Doktorların bağlantı kurmasını 
kolaylaştırması / Importance: Increasing the 
communication between physicians 
242 1 5 3,12 ,842 ,709 
Valid N (listwise) 242      
 
In our research, 4 qualities were defined for pharmaceutical company website 
performance. They were content, design, innovation and objectivity. The factorial 
validity of these criteria was tested by submitting the data for factor analysis, to 
confirm whether or not the theorized dimensions would emerge.  
The items, which were under: “importance of factors in a website” was submitted for 
factor analysis. The analysis revealed the items, which tapped 4 different dimensions:  
The first item, which we had defined as “Content”: Wide Medical Database, 
Currency of Information, Information about Drug Chemistries, Providing access to 
Journals, Information about the Drug Company 
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The second item, which we had defined as “Innovation”: Customized Service, 
Multimedia Applications, Total attractiveness, Facilitating the communication 
between physicians. 
The third item, defined as “Navigation”: Easy Navigation, A good organization of 
the website,  Fast navigation to information 
Objectivity: Objectivity of Information, Compliance with ethics 
The interrelations among the groups are good, only “total attractiveness” seems to fit 
into both innovation and also navigation, however, it would fit better to define it 
under innovation, because navigation relates to utility of the design, not the 
aesthetics. The output of the factor analysis is shown in Table 4.3 below 
Table  4.3: Factor Analysis of Pharmaceutical Website Quality Dimensions 
 
Rotated Component Matrixa 
 Component 
 1 2 3 4 
Önem: Geniş bir Medikal Veritabanı / Importance: 
Wide Medical Database 
,842 ,029 ,073 ,100 
Önem: Bilgilerin Tarafsızlığı / Importance: Objectivity 
of Information 
,190 ,050 ,068 ,885 
Önem: Verilen bilgilerin güncelliği / 
Importance:Currency of Information 
,792 ,096 ,039 ,140 
Önem: İlaçların içeriği ile ilgili detaylı bilgi içermesi / 
Importance: Information about Drug Chemistries 
,792 ,061 ,100 ,064 
Önem: Makalelere ulaşım sağlaması / Importance: 
Providing access to Journals 
,792 ,074 ,035 ,096 
Önem: İlaç firması ile ilgili detaylı bilgi içermesi /  
Importance: Information about the Drug Company 
,697 ,080 ,072 ,067 
Önem: Web sitesinin Kolay Anlaşılır Olması / 
Importance: Easy Navigation 
,100 ,178 ,854 ,161 
Önem: Site düzeninin iyi olması /  Importance: A good 
organization of the website  
,028 ,375 ,822 ,021 
Önem: Etik kurallara uyması / Importance:Compliance 
with ethics 
,153 ,066 ,128 ,881 
Önem: Özel hizmet verilmesi / Importance: 
Customized Service 
,049 ,844 ,103 ,075 
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Önem: Multimedya uygulamalar ile ilginç hale 
getirilmiş olması / Importance:Multimedia Applications 
,084 ,851 ,330 ,042 
Önem: Web sitesinin bütün olarak göze cazip 
görünmesi / Importance:Total attractiveness 
,107 ,637 ,546 -,024 
Önem: Aranan bilgiye hızlı ulaşılabilmesi / Importance: 
Fast navigation to information 
,129 ,226 ,870 ,090 
Önem: Doktorların bağlantı kurmasını kolaylaştırması 
/ Importance: Facilitating the communication between 
physicians 
,141 ,794 ,248 ,054 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Varimax with Kaiser Normalization. 
Later, these 4 factors were tested for the reliability of Cronbach’s Alpha .The first 
one, Content had a Cronbach’s alpha: 0,819.  
“Information about the drug company” seems as the least related item. If it was 
deleted, the value would increase to 0,831. However, we keep this item because the 
values are still acceptable. 
For Objectivity items, Cronbach’s alpha is 0,760. The consistency of items in this 
measure is acceptable. 
For Navigation, items have a reliability coefficient of 0,885, which .reflects a good 
measure of this concept. 
For Innovation,  Cronbach’s alpha is 0,850. In this group of items, multimedia 
applications have the greatest role in the total reliability. If it was deleted, the 
reliability would decrease suddenly to 0,75. 
For the purposes of our analysis, the website quality items included in our analysis 
were multiplied by the physician’s actual degree of finding that item in the website. 
Based on such a sense, we added these together into a single summary measure and 
named it as: “The impression of the website” 
(The importance of the website dimension for the physician) x (The degree of finding 
that dimension in the visited website) =  The impression of the Website. 
In our first set of hypothesis, we had proposed a direct relationship within the 
perceived quality of the website and the perceived image of that company. We will 
test the relationsip via a regression analysis. 
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H1: The more positively physicians perceive the quality of a pharmaceutical 
company website, the more likely they are to form a positive image of that company.  
 
H1 is supported. The R2  for this regression is 0,2.  Beta supports a strong 
relationship, with a value of 0,447. This means that the total quality of the website 
has direct effect on the image of the company. The findings are summarized below in 
table 4.4 
Table  4.4: The Effect of Total  Impression, on Company Image 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,447a ,200 ,197 ,52927 
a. Predictors: (Constant), Toplam Etki / Total Impression 
 
ANOVAb 
Model 
Sum of 
Squares df Mean Square F Sig. 
Regression 16,823 1 16,823 60,054 ,000a 
Residual 67,231 240 ,280   
1 
Total 84,053 241    
a. Predictors: (Constant), Toplam Etki / Total Impression 
b. Dependent Variable: Firmanın toplam imajı / Total image of the company 
 
Coefficientsa 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) 2,159 ,165  13,095 ,000 1 
Toplam Etki / Total 
Impression 
,097 ,012 ,447 7,749 ,000 
a. Dependent Variable: Firmanın toplam imajı / Total image of the company 
 
H1a: The more positively physicians perceive the content of a pharmaceutical 
company website, the more likely they are to form a positive image of that company. 
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H1a is supported. The R2  for this regression is 0,119.  Beta value is 0,345. This 
means that the quality of the content of a website has direct effect on the image of the 
company. The findings are summarized in table 4.5 
 
Table  4.5: The Effect of Content Impression, on Company Image 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,345a ,119 ,115 ,55552 
a. Predictors: (Constant), etkicontent 
 
ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
Regression 9,989 1 9,989 32,368 ,000a 
Residual 74,065 240 ,309   
1 
Total 84,053 241    
a. Predictors: (Constant), etkicontent 
b. Dependent Variable: Firmanın toplam imajı / Total image of the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) 2,627 ,142  18,505 ,000 1 
etkicontent ,057 ,010 ,345 5,689 ,000 
a. Dependent Variable: Firmanın toplam imajı / Total image of the company 
 
H1b: The more positively physicians perceive the navigation of a pharmaceutical 
company website, the more likely they are to form a positive image of that company 
H1b is supported. The R2  for this regression is 0,124.  Beta value is 0,352. This 
means that the quality of the navigation of a website has direct effect on the image of 
the company. The findings are summarized in table 4.6 
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Table  4.6: The Effect of Navigation Impression, on Company Image 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,352a ,124 ,120 ,55387 
a. Predictors: (Constant), etkinavigasyon 
 
ANOVAb 
Model Sum of Squares Df Mean Square F Sig. 
Regression 10,428 1 10,428 33,994 ,000a 
Residual 73,625 240 ,307   
1 
Total 84,053 241    
a. Predictors: (Constant), etkinavigasyon 
b. Dependent Variable: Firmanın toplam imajı / Total image of the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) 2,731 ,122  22,460 ,000 1 
etkinavigasyon ,054 ,009 ,352 5,830 ,000 
a. Dependent Variable: Firmanın toplam imajı / Total image of the company 
 
 
H1c: The more positively physicians perceive the innovativeness of a pharmaceutical 
company website, the more likely they are to form a positive image of that company 
H1c is supported. The R2  for this regression is 0,112.  Beta value is 0,335. This 
means that the quality of the innovation of a website has direct effect on the image of 
the company. The findings are summarized in table 4.7 
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Table  4.7: The Effect of Innovativeness Impression, on Company Image 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,335a ,112 ,108 ,55768 
a. Predictors: (Constant), etkiinnovation 
 
ANOVAb 
Model Sum of Squares Df Mean Square F Sig. 
Regression 9,412 1 9,412 30,264 ,000a 
Residual 74,641 240 ,311   
1 
Total 84,053 241    
a. Predictors: (Constant), etkiinnovation 
b. Dependent Variable: Firmanın toplam imajı / Total image of the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) 2,779 ,120  23,178 ,000 1 
etkiinnovation ,052 ,009 ,335 5,501 ,000 
a. Dependent Variable: Firmanın toplam imajı / Total image of the company 
 
H1d: The more positively physicians perceive the objectivity of a pharmaceutical 
company website, the more likely they are to form a positive image of that company. 
 
H1d is supported. The R2  for this regression is 0,089.  Beta value is 0,298. This 
means that the quality of the objectivity of a website has direct effect on the image of 
the company. However, it does not indicate a very strong relationship. The findings 
are summarized in table 4.8 
 
 
 
 
 
 
64 
Table  4.8: The Effect of Objectivity Impression, on Company Image 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,298a ,089 ,085 ,56491 
a. Predictors: (Constant), etkitotaltarafsızlık 
 
ANOVAb 
Model Sum of Squares Df Mean Square F Sig. 
Regression 7,465 1 7,465 23,391 ,000a 
Residual 76,589 240 ,319   
1 
Total 84,053 241    
a. Predictors: (Constant), etkitotaltarafsızlık 
b. Dependent Variable: Firmanın toplam imajı / Total image of the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) 2,851 ,121  23,553 ,000 1 
etkitotaltarafsızlık ,043 ,009 ,298 4,836 ,000 
a. Dependent Variable: Firmanın toplam imajı / Total image of the company 
 
The regression analysis has shown that our hypotheses are confirmed and that there 
were paths between the impression of a website and company image.  
The regression tests of the second set of hypothesis are below: 
H2: The more positively physicians perceive the image of a company; the more 
likely they are to prescribe that company’s products. 
H2 is supported. As we had estimated, there is a strong relationship between a 
pharmaceutical company’s image and the physicians’ prescription behaviours 
towards that company. R2 value is 0,663, while Beta is 0,814. Results are shown in 
table 4.9 
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Table  4.9: The Effect of Company Image, on Prescription 
 
Model Summary 
Model R R Square Adjusted R Square 
Std. Error of the 
Estimate 
1 ,814a ,663 ,662 ,43953 
a. Predictors: (Constant), Firmanın toplam imajı / Total image of the company 
 
ANOVAb 
Model Sum of Squares Df Mean Square F Sig. 
Regression 91,257 1 91,257 472,377 ,000a 
Residual 46,365 240 ,193   
1 
Total 137,622 241    
a. Predictors: (Constant), Firmanın toplam imajı / Total image of the company 
b. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription behaviour for 
the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) -,305 ,166  -1,841 ,067 1 
Firmanın toplam imajı / 
Total image of the 
company 
1,042 ,048 ,814 21,734 ,000 
a. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription behaviour for 
the company 
The regression tests of the third set of hypothesis are below: 
H3: The more positively physicians perceive the quality of a pharmaceutical 
company website; the more likely they are to prescribe that company’s products. 
 
H3 is supported. The R2 for this regression is 0,127.  Beta value is 0,356. This means 
that the total impression of a website has direct effect on the prescription behaviour 
for that company. The findings are summarized in table 4.10 
 
66 
Table  4.10: The Effect of Total Impression, on Prescription 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,356a ,127 ,123 ,70773 
a. Predictors: (Constant), Toplam Etki / Total Impression 
 
 
ANOVAb 
Model Sum of Squares Df Mean Square F Sig. 
Regression 17,409 1 17,409 34,757 ,000a 
Residual 120,213 240 ,501   
1 
Total 137,622 241    
a. Predictors: (Constant), Toplam Etki / Total Impression 
b. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription 
behaviour for the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) 1,975 ,220  8,958 ,000 1 
Toplam Etki / Total 
Impression 
,098 ,017 ,356 5,896 ,000 
a. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription behaviour for 
the company 
 
H3a: The more positively physicians perceive the content of a pharmaceutical 
company website; the more likely they are to prescribe that company’s products. 
H3a is supported. The R2 for this regression is 0,118.  Beta value is 0,344. This 
means that the content impression of a website has direct effect on the prescription 
behaviour for that company. The findings are summarized in table 4.11 
 
 
67 
 
 
Table  4.11: The Effect of Content Impression, on Prescription 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,344a ,118 ,114 ,71115 
a. Predictors: (Constant), etkicontent 
 
ANOVAb 
Model Sum of Squares Df Mean Square F Sig. 
Regression 16,247 1 16,247 32,125 ,000a 
Residual 121,375 240 ,506   
1 
Total 137,622 241    
a. Predictors: (Constant), etkicontent 
b. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription 
behaviour for the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) 2,250 ,182  12,378 ,000 1 
etkicontent ,073 ,013 ,344 5,668 ,000 
a. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription behaviour 
for the company 
 
H3b: The more positively physicians perceive the navigation of a pharmaceutical 
company website; the more likely they are to prescribe that company’s products. 
H3b is supported. The R2 for this regression is 0,060.  Beta value is 0,245. This is 
not a very strong relationship but still significant The findings are summarized in 
table 4.12 
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Table  4.12: The Effect of Navigation Impression, on Prescription 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,245a ,060 ,056 ,73415 
a. Predictors: (Constant), etkinavigasyon 
 
ANOVAb 
Model Sum of Squares Df Mean Square F Sig. 
Regression 8,267 1 8,267 15,339 ,000a 
Residual 129,355 240 ,539   
1 
Total 137,622 241    
a. Predictors: (Constant), etkinavigasyon 
b. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription 
behaviour for the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) 2,643 ,161  16,399 ,000 1 
etkinavigasyon ,048 ,012 ,245 3,916 ,000 
a. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription behaviour 
for the company 
 
H3c: The more positively physicians perceive the innovativeness of a pharmaceutical 
company website, the more likely they are to prescribe that company’s products. 
H3c is not supported. The R2 for this regression is 0,040.  Beta value is 0,201. This 
means that the innovativeness of a company website does not affect the prescription 
behaviour towards that company. 
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Table  4.13: The Effect of Innovativeness Impression, on Prescription 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,201a ,040 ,036 ,74176 
a. Predictors: (Constant), etkiinnovation 
 
ANOVAb 
Model Sum of Squares Df Mean Square F Sig. 
Regression 5,571 1 5,571 10,125 ,002a 
Residual 132,051 240 ,550   
1 
Total 137,622 241    
a. Predictors: (Constant), etkiinnovation 
b. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription 
behaviour for the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) 2,762 ,159  17,319 ,000 1 
etkiinnovation ,040 ,013 ,201 3,182 ,002 
a. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription behaviour 
for the company 
 
 
H3d: The more positively physicians perceive the objectivity of a pharmaceutical 
company website, the more likely they are to prescribe that company’s products. 
H3d  is supported. The R2  for this regression is 0,055.  Beta value is 0,234. This is 
not a very strong relationship but still significant The findings are summarized in 
table 4.14 
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Table  4.14: The Effect of Objectivity Impression, on Prescription 
 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,234a ,055 ,051 ,73629 
a. Predictors: (Constant), etkitotaltarafsızlık 
 
ANOVAb 
Model Sum of Squares Df Mean Square F Sig. 
Regression 7,514 1 7,514 13,861 ,000a 
Residual 130,108 240 ,542   
1 
Total 137,622 241    
a. Predictors: (Constant), etkitotaltarafsızlık 
b. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription 
behaviour for the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) 2,686 ,158  17,030 ,000 1 
etkitotaltarafsızlık ,043 ,012 ,234 3,723 ,000 
a. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription behaviour for 
the company 
 
Mediation is a hypothesized causal chain in which one variable affects a second 
variable that, in turn, affects a third variable. The intervening variable is the 
mediator. It “mediates” the relationship between a predictor, and an outcome.  
In our model, we had proposed that “image” was the mediating variable between 
impression of a website and prescription behaviour. 
Baron and Kenny (1986) proposed a four step approach in which several regression 
analyses are conducted and significance of the coefficients is examined at each step.  
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The first step is conducting a simple regression analysis with website impression as 
an independent variable and testing its significance on prescription behaviour. We 
have already done that.  
The second step is conducting a simple regression analysis with image predicting 
prescription behaviour. We have also found this relationship significant.  
The third step is conducting a simple regression analysis with website impression 
predicting image. 
We have found all these relationships significant and can proceed to next step, which 
is conducting a multiple regression analysis and testing the effect of website 
impression and image, together on prescription behaviour. The results are listed in 
table 4.15 
The Beta Value was 0,356, in the relationship between website total impression and 
prescription. Now it decreased to 0,11. This shows that there is a partial mediation in 
our model. 
The perceived quality (impression) of a website affects the prescription behaviour 
towards that company, both directly and through increasing its perceived image. 
 Table  4.15: The Mediation Effect 
Model Summary 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 ,814a ,663 ,660 ,44039 
a. Predictors: (Constant), Firmanın toplam imajı / Total image of the 
company, Toplam Etki / Total Impression 
 
ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
Regression 91,270 2 45,635 235,302 ,000a 
Residual 46,352 239 ,194   
1 
Total 137,622 241    
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a. Predictors: (Constant), Firmanın toplam imajı / Total image of the company, Toplam Etki / 
Total Impression 
b. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription 
behaviour for the company 
 
Coefficientsa 
Unstandardized Coefficients 
Standardized 
Coefficients 
Model B Std. Error Beta t Sig. 
(Constant) -,288 ,180  -1,603 ,110 
Toplam Etki / Total 
Impression 
-,003 ,012 -,011 -,257 ,797 
1 
Firmanın toplam imajı / 
Total image of the 
company 
1,048 ,054 ,819 19,515 ,000 
a. Dependent Variable: Firmanın reçetelemede tercih edilme derecesi / The prescription behaviour for 
the company 
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5. CONCLUSION 
The internet is undoubtedly one of the biggest social revolutions of our times and has 
a great potential to contribute to improving worldwide health outcomes by increasing 
health literacy and access to information. We know that healthcare information is the 
number one reason for internet use, and so it should be possible to harness that 
interest even more. However, it’s important to provide a measurable evidence to 
companies for undertaking the effort associated with constructing a reliable, wide 
and innovative online database.  
Much remains to be known about the online marketing management of 
pharmaceutical products. In terms of the promotional mix, findings from this study 
and prior research indicate that promoting drugs is most effective when targeted to 
physicians directly and indirectly through information sources physicians use. While 
physicians rely upon their experiences, they also rely upon medical information.  
Our study reveals two “pathways” that describe why pharmaceutical companies 
should incorporate the Internet into their practice. The first pathway is related to the 
image of the company. A good and physician targeted website helps in increasing the 
image of the company. It has long been recognized that the brand name is the 
dominant cue in decision making by many physicians. A brand provides 
identification and continuity in the marketplace and is the most visible extrinsic cue 
to the physician.  Corporate image represents a powerful link to brand image and 
prescription behaviour.  
 The second pathway goes directly from the website to prescription behaviour. When 
this happens, using the Internet will lead physicians to helpful information, which 
they will utilize in their daily lives. 
All 4 web dimensions that we have defined (content, navigation, innovation and 
objectivity)  have an effect on the prescription behaviour towards a pharmaceutical 
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company.  However, innovativeness of a pharmaceutical website has no direct effect 
on prescription behaviour. However, it still effects prescription behaviour through 
increasing the image of that company. 
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6. MANAGERIAL IMPLICATIONS 
In the last couple of years, the trend for the pharmaceutical industry marketing 
investments has undergone major changes. 
Some years ago, traditional media represented the main communication channels, 
nowadays, the development of new media, the continuous challenges of the market 
due also to stricter government regulations and the not always positive public 
perception of drug marketing have brought pharmaceutical companies to change 
their marketing strategies, preferring new communication channels to dialogue with 
their customers. 
These are reasons leading pharmaceutical industry marketing managers are moving 
investments, historically devoted to traditional media, towards online promotion 
activities. The need to plan investments in a more rational and measurable way is 
certainly one of the main reasons of this trend. The ease in measuring the return on 
investment, which is a characteristic of online promotion channels, together with the 
great interactivity of these tools, allows pharmaceutical companies to keep a more 
direct contact with their users, which makes investments in ads and sales reps less 
efficient. A website, in fact, is more and more perceived as a meeting place with 
one's own customers, a channel to inform but, at the same time, to promote one's own 
brand.  
It is evident, then, that now the most important need in this field is the will to make 
investments which are mainly measurable and effective. The lack of tracking tools, 
data and methodologies capable to precisely evaluate the return of investments made, 
typical of more traditional means, has contributed to the stall phase in which industry 
is now. The planning of strategic online marketing activities and a greater need to 
develop relationships with customers (loyalty) are the needs that pharmaceutical 
marketing professionals perceive to be most urgent and important. Even if today the 
market is not completely ready for these changes, in the very near future the net is 
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certainly going to play a more important role in this field, representing an 
opportunity for development and imposing new strategic choices in pharmaceutical 
industry communication. This study shows clearly that the online pharmaceutical 
marketing spending is tangible and trackeble. 
However, using new technologies like the Internet for marketing purposes is a 
challenge for the pharmaceutical industry. There are undoubtedly many reasons for 
this cautionary approach to new technology. The pharmaceutical industry, for one 
thing, is very heavily regulated. Every aspect of its marketing is closely watched by 
politicians, regulators, and the general public. One false step could means millions in 
lost revenue, not to mention good will. 
Pharmaceutical marketers take into account many factors when deciding the 
marketing mix for a drug: the therapeutic category, the life cycle stage of the drug, 
reach and frequency criteria, past experience, the competitive landscape, return on 
investment (ROI), outside advice, and gut feelings. 
Another factor to consider, especially when dealing with computer-enabled 
promotions (websites, e-mail, podcasts, eDetails, behavioral targeting, etc.) is a risk 
vs. benefit analysis. Impact is determined by reach, credibility, and content richness 
whereas risk can be thought of as potential to cause customer dissatisfaction or 
pushback, increased regulation, negative publicity, etc.  
For these reasons, it is wise to know what the risks are and to balance the risks 
against the benefits. This study also shows what physicians find appropriate and 
favourable in terms of online marketing. 
The use of technology in future marketing channels will provide more convenience, 
personalization and control (as in being able to access and control what you want to 
get) and engagement. All this will increase the impact that these channels have on the 
target audience. 
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7. LIMITATIONS AND FUTURE DIRECTIONS 
Our findings have several limitations. First, the cross-sectional nature of the survey 
arises the need to question the physicians for the “last” website they visited. This 
could lead to a bias, for example, the last webpage they visited can be ,with greater 
possibility, a website that they visit frequently, and a drug that they already 
prescribe.  
Further studies, specifically cohort studies that examine the exposure of physicians to 
health-related information on the Internet over time, are necessary to determine the 
effect more clearly. 
Second, though our sample size is adequate, our survey was only done to a 
judgemental sampling group, of which contact information was available and 
convenient. Therefore it may not be generalized to other populations or settings. 
Third, our instrument measured websites in using the Internet among many activities. 
Many other health-related activities are possible using the Internet, but were not 
brought up by members of our focus groups, so they were not included, assuming 
that they would not be used by enough individuals to allow useful analyses to be 
performed.  
Fourth, our survey relied on self-report of Internet interest and prescription. A more 
valid method may have been to install software on individuals’ computers to record 
websites that were visited, and also follow the prescriptions that they have written, 
by IMS. This would have allowed us to use participant’s actual prescription as a 
dependent variable, rather than self-reported variable. These methods were used 
recently in study examining ways that consumers search for and appraise the quality. 
An area for future exploration is the total number and percentage of physicians who 
are actually using internet 
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In addition, an interesting topic for further research would be an examination of 
consumer targeted web-sites and their effect on doctor prescription behaviour, 
through patients.. 
A final area of useful future research would be to develop methods for arriving at 
optimal combinations of the various online marketing tools.  
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APPENDIX A: IEIS Pharmaceutical Companies Internet Website Application 
Guidelines 
The guidelines consist of four main parts. The subtitles for these parts are aim, 
general rules, home page, site for healthcare professionals. The content of these four 
parts is given as follows: 
1. Aim 
The most significant responsibility of the drug industry is to provide quality and safe 
drugs and to transfer the information concerning these drugs in a true and unbaised 
manner in accordance with the medicinal product pro motion guidelines in order to 
assure their rational use by no doubt. 
To achieve this aim, pharmaceutical companies (drug producers, importers, and 
distributors) can design (and update when in need) websites on the Internet 
comprising information related to their firms, list of their products, and patient 
package inserts approved by the Ministry of Health, information related to the drug 
promotion for the healthcare professionals, information on health issues related to 
their products, and the medical advances. 
2. General rules 
• Internet websites are held subject to the rules of IEIS Medicinal Product Promotion 
Guidelines. 
• Pharmaceutical companies are responsible for their own website design. 
• If personal information is obtained from the visitors of the website, this information 
should be kept secret. 
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3. Home page 
Home page of the pharmaceutical company should have the following 
characteristics: 
• There should not be any pharmaceutical product advertisement in the home page. 
• There should be clear information on the mail address, e-mail address, phone and 
fax number of the pharmaceutical company which owns the website. 
• The last date the website has been updated should be indicated. 
• It should be indicated for whom the website (or the sections of the website) is 
designed for. Information to the public and the links should be on the home page. 
• In case of instructions to the public when diseases are described, references should 
be indicated. 
• The information should be appropriate for the intended target group. 
• There should be a phrase stating that “This website cannot replace regular 
discussions with your doctor and pharmacist”. 
• Information for the healthcare professionals and for the public should be seperate in 
two sections. At the top of the section designed for healthcare professionals there 
should be a disclaimer stating that the section is designed solely for healthcare 
professionals. Also there can be a password for preventing the entrance of 
unauthorized persons. 
Owner of the website assigns someone/a body responsible for the website and the 
name of this responsible person/body is indicated at home page of the website. 
4. Sites for healthcare professionals 
• In these pages given information and promotional activities should be in 
accordance with the “Medicinal Product Promotion Guidelines” prepared by IEIS. 
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• Information on the website should be prepared by the experts on the subject and the 
designer of the site should be indicated with its references. Otherwise there should be 
a clarification. 
• In product promotion any information conflicted with the patient package insert and 
brief product information that are approved by the Ministry of Health cannot be used 
advocating/ stating that it is approved in other countries. 
• When providing “links” to other sites related to the medicinal products there should 
be a disclaimer stating that the information in that site is not under the responsibility 
of the pharmaceutical company, activities may not be in compliant with the Turkish 
Republic regulations and texts can be different than the ones approved by the 
Ministry of Health. 
Due to the changes made by the Ministry of Health, updating of the information 
related to the products is under the responsibility of the owner of the website of the 
pharmaceutical company. 
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APPENDIX B : The Questionnaire 
 
TÜRKİYE’DE HEKİMLERİN, İLAÇ FİRMALARININ İNTERNET ÜZERİNDEKİ 
AKTİVİTELERİNE KARI TUTUMU İLE İLGİLİ BİR ARATIRMA 
 
Bu anketi tamamlamanız, yukarıda ismi geçen akademik araştırmaya büyük katkı sağlayacaktır. 
Doktorlarıni ilaç firmalarının internet üzerindeki aktivitelerine karşı tutumu ile ilgili en doğru bilgiyi 
 siz doktorlardan alabileceğimiz için, bu anketi içtenlikle cevaplamanızın önemi büyüktür. 
Cevaplarınız ve kimliğiniz kesinlikle gizli kalacak ve bu araştırmanın sonuçları, tamamen akademik 
araştırmalar için kullanılacaktır. Katkınız için teşekkürler. 
 
 
 
 
İşletme Mühendisliği Bölümü 
Feb Bilimleri  Enstitüsü 
İstanbul Teknik Üniversitesi 
 
 
 Lütfen her sorudaki uygun şıkkı işaretleyiniz 
 Eğer cevap veremeyeceğiniz bir soru varsa geçip ankete devam ediniz. 
Cevaplandırabildiğiniz kadar çok soru cevaplandırınız. 
Yrd. Doç. Dr. 
Ayşe Banu Elmadağ Baş 
 
Pelin Yılmaz  
Yüksek Lisans Öğrencisi 
 
 
1- Mesleki konularla ilgili internet’i kullanıyor musunuz?  
 
 ?  Evet   ? Hayır(Anketi sonlandırın) 
 
 
2-  Son 2 ay içinde bir ilaç firmasının internet sitesini ziyaret ettiniz mi?  
 
?  Evet       ? Hayır(Anketi sonlandırın) 
 
 
3- İlaç firmalarının web sitelerine, hangi sıklıkta giriyorsunuz? 
  
?  Haftada birkaç kez   ?  2 haftada bir kez   ?  2 ayda bir kez 
?  Haftada bir kez         ?  Ayda bir kez              ?  3 ayda bir veya daha seyrek  
              
 
4- İlaç firmalarının web sitelerinde ortalama ne kadar zaman geçiriyorsunuz? 
 
?  Ayda 10 saatten fazla     ?  Ayda 5-6 saat        ?  Ayda 1-2 saat  
?  Ayda 7-10 saat          ?  Ayda 3-4 saat   ?  Ayda 1 saatten az 
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5- Aşağıdaki listede, bir ilaç firmasının web sitesinde bulunabilecek bazı özellikleri kendiniz 
için; 
       1: Hiç önemli değil  2: Önemli değil   3: Ne önemli, ne de önemsiz   4: Önemli  5: Çok önemli  
anlamına gelmek üzere, 1 ile 5 arasında puanlandırınız: 
Bir ilac firmasinin web sitesini kullanırken .....  
 
 
Hiç Önemli 
Değil 
Önemli 
Değil 
Ne Önemli 
Ne Önemsiz Önemli 
Çok 
Önemli 
Geniş bir medikal veritabanı olması 1 2 3 4 5 
Medikal bilgilerin tarafsızlığı 1 2 3 4 5 
Verilen bilgilerin güncelliği 1 2 3 4 5 
İlaçların içeriği ile ilgili detaylı bilgi olmasi 1 2 3 4 5 
İlaç firması ile ilgili detaylı bilgi içermesi 1 2 3 4 5 
Makalelere ulaşım sağlaması 1 2 3 4 5 
Etik kurallara uyması 1 2 3 4 5 
Web sitesinin kolay anlaşılabilir olması 1 2 3 4 5 
Aranan bilgiye hızlı ulaşılabilmesi 1 2 3 4 5 
Site düzeninin iyi olması 1 2 3 4 5 
Web sitesinin bütün olarak göze cazip görünmesi 1 2 3 4 5 
Multimedya uygulamalar ile ilginç hale getirilmiş olması 1 2 3 4 5 
Kayıt olunduğunda, kişiye özel hizmet sunulması 1 2 3 4 5 
Diğer hekimlerle bağlantı kurmaya olanak veren bir 
platform içermesi 
1 2 3 4 5 
6- Son ziyaret ettiğiniz, ilaç firmasına ait web sitesi hangisiydi?.___________________ 
 
7- Son ziyaret ettiğiniz ilaç firmasına ait web sitesini düşündüğünüzde, aşağıdaki listedeki 
özellikleri, sitede bulunma derecelerine göre 1-5 arasında puanlandırınız : 
1: kesinlikle yetersiz    2: yetersiz    3: ne yeterli ne yetersiz    4: yeterli    5: kesinlikle yeterli  
 
Web sitesini son ziyaret ettiğiniz ilac firmasinin web sitesinde .... 
 
 
Kesinlikle 
yetersiz Yetersiz 
Ne yeterli 
Ne 
yetersiz 
Yeterli Kesinlikle Yeterli 
Medikal veritabanı  1 2 3 4 5 
Medikal bilgilerin tarafsızlığı 1 2 3 4 5 
Verilen bilgilerin güncelliği 1 2 3 4 5 
İlaçların içeriği ile ilgili bilginin detay düzeyi 1 2 3 4 5 
İlaç firması hakkındaki bilginin detayı 1 2 3 4 5 
Makalelere ulaşım sağlaması 1 2 3 4 5 
Etik kurallara uyması 1 2 3 4 5 
Web sitesinin kolay anlaşılabilir olması 1 2 3 4 5 
Aranan bilgiye ulaşım hızı 1 2 3 4 5 
Site düzeni  1 2 3 4 5 
Web sitesinin bütün olarak göze cazip görünmesi 1 2 3 4 5 
Multimedya uygulamalarının ilgi çekiciliği  1 2 3 4 5 
Kayıt olunduğunda, kişiye özel hizmet sunulması 1 2 3 4 5 
Diğer hekimlerle bağlantı kurma olanakları 1 2 3 4 5 
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8 - Son ziyaret ettiğiniz ilaç firmasına ait web sitesini hazırlayan ilaç firmasını 
düşündüğünüzde, aşağıdaki cümleleri, size uyma derecelerine göre 1-5 arasında 
puanlandırınız: 
1: Kesinlikle katılmıyorum  2: Katılmıyorum  3: Ne katılıyor, ne de katılmıyorum    4: Katılıyorum   
5: Kesinlikle Katılıyorum.  
 
 
Kesinlikle 
Katılmıyorum 
Katılmı-
yorum 
Ne katılıyor 
Ne 
katılmıyorum 
Katılı-
yorum 
Kesinlikle 
Katılıyorum
Bu firma hakkında düşüncelerim olumlu 1 2 3 4 5 
Bu firmaya güveniyorum 1 2 3 4 5 
Bu firmanın saygın bir firma olduğunu 
düşünüyorum 
1 2 3 4 5 
Bu firmanın ürünlerinin doktorlar tarafından 
reçetelenmede tercih edildiğini düşünüyorum 
1 2 3 4 5 
Bu firmanın ürünleri benim uzmanlık alanımda 
olsaydı reçetelerdim 
1 2 3 4 5 
Bu firmanın ürünlerini reçetelemeleri için 
meslektaşlarıma tavsiye ederim 
1 2 3 4 5 
 
9- Bu firma hakkındaki genel fikrinizi, aşağıdaki en uygun seçeneği işaretleyerek belirtiniz. 
Çok Olumsuz  1 2 3 4 5 6 7 Çok Olumlu 
 
10- Sizce diğer insanların bu firma hakkındaki genel düşünceleri en çok hangisine 
uymaktadır? Lütfen en uygun seçeneği işaretleyiniz.  
Çok Olumsuz  1 2 3 4 5 6 7 Çok Olumlu 
 
11- Bu firmayı, ilaç sektöründeki diğer firmalarla karşılaştırdığınızda onlara gore konumu 
sizce nedir? Lütfen en uygun şıkkı işaretleyiniz.  
Çok Kötü  1 2 3 4 5 6 7 Çok İyi 
 
12- Yaşınız? ________________________ 
 
13- Cinsiyetiniz?  ?  Erkek  ?  Kadın 
 
14- Yaşadığınız Şehir? ________________________ 
 
15- Uzmanlığınız?____________________________ 
 
16- Çalıştığınız kurum? 
 
?  Özel Hastane  ?  Özel Muayenehane  ?  Poliklinik 
 
?  Devlet Hastanesi  ?  Sağlık Ocağı  ?  Diğer ________________ 
 
 
17- Haftada ortalama kaç hasta görüyorsunuz? ________________ 
 
CEVAPLARINIZ İÇİN ÇOK TEŞEKKÜRLER… 
 
